0001435064 false 9/30 2021 Q3 0 0 0 0 P5Y P3Y P5Y P7Y P15Y 0001435064 2020-10-01 2021-06-30 0001435064 us-gaap:CommonStockMember 2020-10-01 2021-06-30 0001435064 CETX:Series1PreferredStockMember 2020-10-01 2021-06-30 0001435064 CETX:Series1WarrantsMember 2020-10-01 2021-06-30 0001435064 2021-08-13 0001435064 2021-06-30 0001435064 2020-09-30 0001435064 CETX:SeriesOnePreferredStockMember 2021-06-30 0001435064 CETX:SeriesOnePreferredStockMember 2020-09-30 0001435064 us-gaap:SeriesAPreferredStockMember 2021-06-30 0001435064 us-gaap:SeriesAPreferredStockMember 2020-09-30 0001435064 us-gaap:SeriesCPreferredStockMember 2021-06-30 0001435064 us-gaap:SeriesCPreferredStockMember 2020-09-30 0001435064 2021-04-01 2021-06-30 0001435064 2020-04-01 2020-06-30 0001435064 2019-10-01 2020-06-30 0001435064 CETX:Series1PreferredStockMember 2020-09-30 0001435064 us-gaap:CommonStockMember 2020-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001435064 us-gaap:RetainedEarningsMember 2020-09-30 0001435064 us-gaap:TreasuryStockMember 2020-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001435064 us-gaap:NoncontrollingInterestMember 2020-09-30 0001435064 CETX:Series1PreferredStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:SeriesAPreferredStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:SeriesCPreferredStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001435064 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001435064 us-gaap:TreasuryStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001435064 2020-10-01 2020-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0001435064 CETX:Series1PreferredStockMember 2020-12-31 0001435064 us-gaap:SeriesAPreferredStockMember 2020-12-31 0001435064 us-gaap:SeriesCPreferredStockMember 2020-12-31 0001435064 us-gaap:CommonStockMember 2020-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001435064 us-gaap:RetainedEarningsMember 2020-12-31 0001435064 us-gaap:TreasuryStockMember 2020-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001435064 2020-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2020-12-31 0001435064 CETX:Series1PreferredStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001435064 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001435064 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001435064 2021-01-01 2021-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001435064 CETX:Series1PreferredStockMember 2021-03-31 0001435064 us-gaap:SeriesAPreferredStockMember 2021-03-31 0001435064 us-gaap:SeriesCPreferredStockMember 2021-03-31 0001435064 us-gaap:CommonStockMember 2021-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001435064 us-gaap:RetainedEarningsMember 2021-03-31 0001435064 us-gaap:TreasuryStockMember 2021-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001435064 2021-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-03-31 0001435064 CETX:Series1PreferredStockMember 2021-04-01 2021-06-30 0001435064 us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-06-30 0001435064 us-gaap:SeriesCPreferredStockMember 2021-04-01 2021-06-30 0001435064 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001435064 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001435064 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001435064 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001435064 CETX:Series1PreferredStockMember 2021-06-30 0001435064 us-gaap:CommonStockMember 2021-06-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001435064 us-gaap:RetainedEarningsMember 2021-06-30 0001435064 us-gaap:TreasuryStockMember 2021-06-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001435064 us-gaap:NoncontrollingInterestMember 2021-06-30 0001435064 CETX:Series1PreferredStockMember 2019-09-30 0001435064 us-gaap:SeriesAPreferredStockMember 2019-09-30 0001435064 us-gaap:SeriesCPreferredStockMember 2019-09-30 0001435064 us-gaap:CommonStockMember 2019-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001435064 us-gaap:RetainedEarningsMember 2019-09-30 0001435064 us-gaap:TreasuryStockMember 2019-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001435064 2019-09-30 0001435064 us-gaap:NoncontrollingInterestMember 2019-09-30 0001435064 CETX:Series1PreferredStockMember 2019-10-01 2019-12-31 0001435064 us-gaap:SeriesAPreferredStockMember 2019-10-01 2019-12-31 0001435064 us-gaap:SeriesCPreferredStockMember 2019-10-01 2019-12-31 0001435064 us-gaap:CommonStockMember 2019-10-01 2019-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2019-10-01 2019-12-31 0001435064 us-gaap:RetainedEarningsMember 2019-10-01 2019-12-31 0001435064 us-gaap:TreasuryStockMember 2019-10-01 2019-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-10-01 2019-12-31 0001435064 2019-10-01 2019-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2019-10-01 2019-12-31 0001435064 CETX:Series1PreferredStockMember 2019-12-31 0001435064 us-gaap:SeriesAPreferredStockMember 2019-12-31 0001435064 us-gaap:SeriesCPreferredStockMember 2019-12-31 0001435064 us-gaap:CommonStockMember 2019-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001435064 us-gaap:RetainedEarningsMember 2019-12-31 0001435064 us-gaap:TreasuryStockMember 2019-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001435064 2019-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2019-12-31 0001435064 CETX:Series1PreferredStockMember 2020-01-01 2020-03-31 0001435064 us-gaap:SeriesAPreferredStockMember 2020-01-01 2020-03-31 0001435064 us-gaap:SeriesCPreferredStockMember 2020-01-01 2020-03-31 0001435064 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001435064 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001435064 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001435064 2020-01-01 2020-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001435064 CETX:Series1PreferredStockMember 2020-03-31 0001435064 us-gaap:SeriesAPreferredStockMember 2020-03-31 0001435064 us-gaap:SeriesCPreferredStockMember 2020-03-31 0001435064 us-gaap:CommonStockMember 2020-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001435064 us-gaap:RetainedEarningsMember 2020-03-31 0001435064 us-gaap:TreasuryStockMember 2020-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001435064 2020-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2020-03-31 0001435064 CETX:Series1PreferredStockMember 2020-04-01 2020-06-30 0001435064 us-gaap:SeriesAPreferredStockMember 2020-04-01 2020-06-30 0001435064 us-gaap:SeriesCPreferredStockMember 2020-04-01 2020-06-30 0001435064 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001435064 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001435064 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001435064 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001435064 CETX:Series1PreferredStockMember 2020-06-30 0001435064 us-gaap:SeriesAPreferredStockMember 2020-06-30 0001435064 us-gaap:SeriesCPreferredStockMember 2020-06-30 0001435064 us-gaap:CommonStockMember 2020-06-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001435064 us-gaap:RetainedEarningsMember 2020-06-30 0001435064 us-gaap:TreasuryStockMember 2020-06-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001435064 2020-06-30 0001435064 us-gaap:NoncontrollingInterestMember 2020-06-30 0001435064 CETX:ViconIndustriesIncMember 2019-08-14 2019-08-15 0001435064 CETX:VirtualDriverInteractiveMember 2020-10-25 2020-10-26 0001435064 CETX:VirtualDriverInteractiveMember 2020-10-26 0001435064 srt:ScenarioForecastMember CETX:InstallmentOneMember 2021-10-25 2021-10-26 0001435064 srt:ScenarioForecastMember CETX:InstallmentTwoMember 2022-10-25 2022-10-26 0001435064 2021-05-31 0001435064 CETX:MasterpieceVRMember 2020-11-13 0001435064 CETX:IncorrectlyHandledAndAccountedMember us-gaap:DisputesMember 2021-02-22 2021-02-23 0001435064 CETX:IncorrectlyHandledAndAccountedMember us-gaap:DisputesMember 2016-10-01 2017-09-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember us-gaap:DisputesMember 2017-10-01 2018-09-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember 2017-10-01 2018-09-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember 2018-09-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember 2021-02-26 0001435064 CETX:IncorrectlyHandledAndAccountedMember 2020-10-01 2021-06-30 0001435064 srt:ScenarioPreviouslyReportedMember 2020-09-30 0001435064 CETX:AdjustmentOfNetValueOfIntangibleAssetsMember 2020-09-30 0001435064 CETX:RestatementOnDividendsMember 2020-09-30 0001435064 CETX:CumulativeEffectOfDerecognitionOfExpensesMember 2020-09-30 0001435064 CETX:LossOnAmountsTransferredToFirstCommercialMember 2020-09-30 0001435064 CETX:CumulativeEffectOfCurrencyTranslationMember 2020-09-30 0001435064 srt:ScenarioPreviouslyReportedMember 2020-04-01 2020-06-30 0001435064 srt:RestatementAdjustmentMember 2020-04-01 2020-06-30 0001435064 srt:ScenarioPreviouslyReportedMember 2019-10-01 2020-06-30 0001435064 srt:RestatementAdjustmentMember 2019-10-01 2020-06-30 0001435064 srt:ScenarioPreviouslyReportedMember 2019-09-30 0001435064 srt:RestatementAdjustmentMember 2019-09-30 0001435064 srt:ScenarioPreviouslyReportedMember 2020-06-30 0001435064 srt:RestatementAdjustmentMember 2020-06-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember 2020-10-01 2021-06-30 0001435064 CETX:PreferredStockAndOutstandingOptionsMember CETX:SettlementAgreementMember CETX:AronGovilMember 2021-02-26 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember us-gaap:SeriesAPreferredStockMember 2020-10-01 2021-06-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember us-gaap:SeriesCPreferredStockMember 2020-10-01 2021-06-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember CETX:SeriesOnePreferredStockMember 2020-10-01 2021-06-30 0001435064 CETX:SettlementAgreementMember 2021-02-25 2021-02-26 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember 2021-02-25 2021-02-26 0001435064 us-gaap:WarrantMember 2021-04-01 2021-06-30 0001435064 us-gaap:WarrantMember 2020-04-01 2020-06-30 0001435064 us-gaap:WarrantMember 2020-10-01 2021-06-30 0001435064 us-gaap:WarrantMember 2019-10-01 2020-06-30 0001435064 us-gaap:EmployeeStockOptionMember 2021-04-01 2021-06-30 0001435064 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-06-30 0001435064 us-gaap:EmployeeStockOptionMember 2020-10-01 2021-06-30 0001435064 us-gaap:EmployeeStockOptionMember 2019-10-01 2020-06-30 0001435064 CETX:AdvancedTechnologiesMember 2021-04-01 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember 2020-04-01 2020-06-30 0001435064 CETX:AdvancedTechnologiesMember 2020-10-01 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember 2019-10-01 2020-06-30 0001435064 CETX:IndustrialServicesMember 2021-04-01 2021-06-30 0001435064 CETX:IndustrialServicesMember 2020-04-01 2020-06-30 0001435064 CETX:IndustrialServicesMember 2020-10-01 2021-06-30 0001435064 CETX:IndustrialServicesMember 2019-10-01 2020-06-30 0001435064 CETX:AdvancedTechnologiesMember 2020-06-30 0001435064 CETX:AdvancedTechnologiesMember 2020-09-30 0001435064 CETX:IndustrialServicesMember 2020-06-30 0001435064 CETX:IndustrialServicesMember 2020-09-30 0001435064 us-gaap:SegmentDiscontinuedOperationsMember 2020-06-30 0001435064 us-gaap:SegmentDiscontinuedOperationsMember 2020-09-30 0001435064 us-gaap:FairValueInputsLevel1Member CETX:MarketableSecuritiesMember 2021-06-30 0001435064 us-gaap:FairValueInputsLevel2Member CETX:MarketableSecuritiesMember 2021-06-30 0001435064 us-gaap:FairValueInputsLevel3Member CETX:MarketableSecuritiesMember 2021-06-30 0001435064 CETX:MarketableSecuritiesMember 2021-06-30 0001435064 us-gaap:FairValueInputsLevel3Member CETX:MasterpieceVRMember 2021-06-30 0001435064 CETX:MasterpieceVRMember 2021-06-30 0001435064 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001435064 us-gaap:FairValueInputsLevel2Member 2021-06-30 0001435064 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001435064 us-gaap:LandMember 2021-06-30 0001435064 us-gaap:LandMember 2020-09-30 0001435064 CETX:BuildingAndLeaseholdImprovementsMember 2021-06-30 0001435064 CETX:BuildingAndLeaseholdImprovementsMember 2020-09-30 0001435064 us-gaap:FurnitureAndFixturesMember 2021-06-30 0001435064 us-gaap:FurnitureAndFixturesMember 2020-09-30 0001435064 us-gaap:SoftwareDevelopmentMember 2021-06-30 0001435064 us-gaap:SoftwareDevelopmentMember 2020-09-30 0001435064 CETX:TradeShowDisplayMember 2021-06-30 0001435064 CETX:TradeShowDisplayMember 2020-09-30 0001435064 us-gaap:MachineryAndEquipmentMember 2021-06-30 0001435064 us-gaap:MachineryAndEquipmentMember 2020-09-30 0001435064 CETX:IndustrialServicesMember 2021-06-30 0001435064 srt:MinimumMember 2021-06-30 0001435064 srt:MaximumMember 2021-06-30 0001435064 us-gaap:OtherLiabilitiesMember 2021-06-30 0001435064 us-gaap:OtherLiabilitiesMember 2020-09-30 0001435064 CETX:AssetPurchaseAgreementMember CETX:GriffinFiltersLLCMember CETX:DuconTechnologiesIncMember CETX:AronGovilMember 2019-08-30 2019-08-31 0001435064 CETX:DuconTechnologiesIncMember 2021-06-30 0001435064 CETX:DuconTechnologiesIncMember 2020-09-30 0001435064 CETX:GriffinFiltersLLCMember 2020-10-01 2021-06-30 0001435064 CETX:GriffinFiltersLLCMember 2021-06-30 0001435064 CETX:FultonBankMember 2015-12-15 0001435064 CETX:FultonBankOneMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-12-15 0001435064 CETX:FultonBankOneMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-06-30 0001435064 CETX:AdvancedIndustrialServicesIncMember 2015-12-13 2015-12-15 0001435064 CETX:AdvancedIndustrialServicesIncMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-12-13 2015-12-15 0001435064 CETX:FultonBankMember 2021-06-30 0001435064 CETX:FultonBankMember 2015-12-13 2015-12-15 0001435064 CETX:FultonBankMember CETX:NotesPayableDueOnDecemberFifteenTwoThousandTwentyMember 2015-12-15 0001435064 CETX:FultonBankMember CETX:NotesPayableDueOnDecemberFifteenTwoThousandTwentyMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-12-13 2015-12-15 0001435064 CETX:FultonBankMember CETX:NotesPayableDueOnDecemberFifteenTwoThousandTwentyMember 2021-06-30 0001435064 CETX:FultonBankMember CETX:NotesPayableDueOnDecemberFifteenTwoThousandTwentyMember 2015-12-13 2015-12-15 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeMember CETX:FultonBankMember 2018-05-01 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeMember us-gaap:LondonInterbankOfferedRateLIBORMember CETX:FultonBankMember 2018-04-28 2018-05-01 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeMember CETX:FultonBankMember 2021-06-30 0001435064 CETX:AdvancedIndustrialServicesIncMember CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeMember 2018-04-28 2018-05-01 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeMember CETX:FultonBankMember 2020-01-28 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeMember us-gaap:LondonInterbankOfferedRateLIBORMember CETX:FultonBankMember 2020-01-27 2020-01-28 0001435064 CETX:NotePayableDueOnMayOneTwoThousandTwentyThreeMember CETX:FultonBankMember 2021-06-30 0001435064 CETX:AdvancedIndustrialServicesIncMember CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeMember 2020-01-27 2020-01-28 0001435064 CETX:IndependentThirdPartyMember 2019-12-23 0001435064 CETX:IndependentThirdPartyMember 2019-12-22 2019-12-23 0001435064 CETX:IndependentThirdPartyMember 2020-04-24 0001435064 CETX:IndependentThirdPartyMember 2020-04-23 2020-04-24 0001435064 CETX:IndependentThirdPartyMember 2020-09-30 0001435064 CETX:IndependentThirdPartyMember 2020-09-29 2020-09-30 0001435064 CETX:TermLoanAgreementMember 2020-03-03 0001435064 CETX:TermLoanAgreementMember 2020-03-02 2020-03-03 0001435064 CETX:TermLoanAgreementMember CETX:OneYearMember 2020-03-02 2020-03-03 0001435064 CETX:AdvancedIndustrialServicesIncMember 2020-01-28 0001435064 CETX:AdvancedIndustrialServicesIncMember CETX:FultonBankMember 2020-01-28 0001435064 CETX:AdvancedIndustrialServicesIncMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-28 0001435064 CETX:AdvancedIndustrialServicesIncMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-06-30 0001435064 CETX:AdvancedIndustrialServicesIncMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-27 2020-01-28 0001435064 CETX:PaycheckProtectionProgramMember 2020-05-31 0001435064 CETX:PaycheckProtectionProgramMember 2020-09-30 0001435064 CETX:PaycheckProtectionProgramMember 2021-04-01 2021-04-30 0001435064 CETX:PaycheckProtectionProgramMember 2021-06-01 2021-06-30 0001435064 CETX:PaycheckProtectionProgramMember 2021-01-24 0001435064 CETX:PaycheckProtectionProgramMember 2021-04-17 0001435064 CETX:SeriesOnePreferredStockMember srt:MinimumMember 2020-03-30 0001435064 CETX:SeriesOnePreferredStockMember srt:MaximumMember 2020-03-30 0001435064 CETX:SeriesOnePreferredStockMember 2020-10-01 2021-06-30 0001435064 CETX:SeriesOnePreferredStockMember CETX:TermLoanAgreementMember 2021-04-01 2021-06-30 0001435064 us-gaap:SeriesCPreferredStockMember 2019-10-03 0001435064 us-gaap:SeriesCPreferredStockMember 2019-10-02 2019-10-03 0001435064 CETX:NotesPayableMember us-gaap:CommonStockMember 2020-10-01 2021-06-30 0001435064 CETX:NotesPayableMember 2021-06-30 0001435064 CETX:NotesPayableMember 2020-10-01 2021-06-30 0001435064 CETX:NotesPayableMember us-gaap:CommonStockMember 2021-05-29 2021-06-30 0001435064 CETX:NotesPayableMember 2021-05-29 2021-06-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember us-gaap:SeriesAPreferredStockMember 2021-02-27 2021-03-31 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember us-gaap:SeriesCPreferredStockMember 2021-02-25 2021-03-31 0001435064 CETX:IncorrectlyHandledAndAccountedMember CETX:SettlementAgreementMember CETX:AronGovilMember CETX:SeriesOnePreferredStockMember 2021-02-25 2021-03-31 0001435064 stpr:NY 2021-06-30 0001435064 stpr:NY 2020-10-01 2021-06-30 0001435064 CETX:ISSegmentMember CETX:ManchesterMember 2021-06-30 0001435064 CETX:ISSegmentMember CETX:YorkMember 2021-06-30 0001435064 CETX:ISSegmentMember CETX:EmigsvilleMember 2021-06-30 0001435064 CETX:ISSegmentMember CETX:EmigsvilleMember 2020-10-01 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:PuneMember 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:PuneMember 2020-10-01 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:PuneMember CETX:INRMember 2020-10-01 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:HauppaugeMember 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:HauppaugeMember 2020-10-01 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:HampshireMember 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:HampshireMember 2020-10-01 2021-06-30 0001435064 CETX:AdvancedTechnologiesMember CETX:HampshireMember CETX:GBPMember 2020-10-01 2021-06-30 0001435064 us-gaap:SubsequentEventMember 2021-06-28 2021-07-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares CETX:Segments xbrli:pure utr:sqft iso4217:INR iso4217:GBP

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the quarterly period ended June 30, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the transition period from ___________to ____________

Commission File Number 001-37464

CEMTREX, INC.

(Exact name of registrant as specified in its charter)

Delaware |  | 30-0399914
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

276 Greenpoint Ave, Suite 208, Brooklyn, NY |  | 11222
(Address of principal executive offices) |  | (Zip Code)

631-756-9116
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading symbol |  | Name of each exchange on which registered
Common Stock |  | CETX |  | Nasdaq Capital Market
Series 1 Preferred Stock |  | CETXP |  | Nasdaq Capital Market
Series 1 Warrants |  | CETXW |  | Nasdaq Capital Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ | Accelerated filer ☐
Non-accelerated filer ☒ | Smaller reporting company ☒
| Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes ☒ No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of August 13, 2021, the issuer had 20,782,194 shares of common stock issued and outstanding.

Table of Contents

CEMTREX, INC. AND SUBSIDIARIES

INDEX

|  | Page
PART I. FINANCIAL INFORMATION |
Item 1. Financial Statements |
| Condensed Consolidated Balance Sheets as of June 30, 2021 (Unaudited) and September 30, 2020 (Restated) | 3
| Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss) for the three months ended June 30, 2021 (Unaudited) and June 30, 2020 (Restated) | 4
| Consolidated Statement of Stockholders’ Equity for the nine months ended June 30, 2021 (Unaudited)/(Restated) | 5
| Consolidated Statement of Stockholders’ Equity for the nine months ended June 30, 2020 (Unaudited)/(Restated) | 6
| Condensed Consolidated Statements of Cash Flow for the nine months ended June 30, 2021 (Unaudited) and June 30, 2020 (Restated) | 7
| Notes to Unaudited Condensed Consolidated Financial Statements | 9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 23
Item 4. Controls and Procedures | 28
PART II. OTHER INFORMATION |
Item 1. Legal Proceedings | 29
Item 1A Risk Factors | 29
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 29
Item 6. Exhibits | 30
SIGNATURES | 31

2

Part I. Financial Information

Item 1. Financial Statements

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

|  | (UNAUDITED) |  |  | (Restated) |
|  | June 30, |  |  | September 30, |
|  | 2021 |  |  | 2020 |
Assets |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and equivalents |  | $ | 12,879,278 |  |  | $ | 19,490,061 |
Restricted cash |  |  | 1,690,873 |  |  |  | 1,582,798 |
Short-term investments |  |  | 452,175 |  |  |  | 887,746 |
Trade receivables, net |  |  | 5,234,216 |  |  |  | 6,686,797 |
Trade receivables - related party |  |  | 1,505,789 |  |  |  | 1,432,209 |
Inventory –net of allowance for inventory obsolescence |  |  | 8,669,397 |  |  |  | 6,793,806 |
Prepaid expenses and other assets |  |  | 2,164,367 |  |  |  | 1,188,317 |
Total current assets |  |  | 32,596,095 |  |  |  | 38,061,734 |
Property and equipment, net |  |  | 7,236,755 |  |  |  | 6,961,751 |
Right-of-use assets |  |  | 3,098,523 |  |  |  | 2,728,380 |
Assets held for sale |  |  | 8,323,321 |  |  |  | 8,323,321 |
Goodwill |  |  | 5,886,096 |  |  |  | 4,370,894 |
Other |  |  | 1,094,429 |  |  |  | 744,207 |
Total Assets |  | $ | 58,235,219 |  |  | $ | 61,190,287 |
Liabilities & Stockholders’ Equity (Deficit) |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 2,888,144 |  |  | $ | 2,857,817 |
Short-term liabilities |  |  | 6,381,047 |  |  |  | 7,034,510 |
Lease liabilities - short-term |  |  | 840,016 |  |  |  | 721,036 |
Deposits from customers |  |  | 39,227 |  |  |  | 29,660 |
Accrued expenses |  |  | 2,476,812 |  |  |  | 2,392,487 |
Deferred revenue |  |  | 1,794,187 |  |  |  | 1,651,784 |
Accrued income taxes |  |  | 331 |  |  |  | 89,318 |
Total current liabilities |  |  | 14,419,764 |  |  |  | 14,776,612 |
Long-term liabilities |  |  |  |  |  |  |  |
Loans payable to bank |  |  | 1,046,504 |  |  |  | 1,871,201 |
Long-term lease liabilities |  |  | 2,261,148 |  |  |  | 2,027,406 |
Notes payable |  |  | 3,079,743 |  |  |  | 6,029,999 |
Mortgage payable |  |  | 2,282,409 |  |  |  | 2,355,542 |
Other long-term liabilities |  |  | 1,078,752 |  |  |  | 1,063,733 |
Paycheck Protection Program Loans |  |  | 2,871,161 |  |  |  | 2,169,437 |
Deferred Revenue - long-term |  |  | 449,563 |  |  |  | 467,329 |
Total long-term liabilities |  |  | 13,069,280 |  |  |  | 15,984,647 |
Total liabilities |  |  | 27,489,044 |  |  |  | 30,761,259 |
Commitments and contingencies |  |  | - |  |  |  | - |
Shareholders’ equity |  |  |  |  |  |  |  |
Preferred stock , $0.001 par value, 10,000,000 shares authorized, |  |  |  |  |  |  |  |
Series 1, 3,000,000 shares authorized, 1,885,151 shares issued and outstanding as of June 30, 2021 and 2,156,784 shares issued and outstanding as of September 30, 2020 (liquidation value of $10 per share) |  |  | 1,885 |  |  |  | 2,157 |
Series A, 1,000,000 shares authorized, zero shares issued and outstanding at June 30, 2021 and 1,000,000 shares issued and outstanding at September 30, 2020 |  |  | - |  |  |  | 1,000 |
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at June 30, 2021 and 100,000 shares issued and outstanding at September 30, 2020 |  |  | 50 |  |  |  | 100 |
Common stock, $0.001 par value, 50,000,000 shares authorized, 18,711,463 shares issued and outstanding at June 30, 2021 and 17,622,539 shares issued and outstanding at September 30, 2020 |  |  | 18,711 |  |  |  | 17,623 |
Preferred stock value |  |  | - |  |  |  | - |
Additional paid-in capital |  |  | 58,846,576 |  |  |  | 60,221,766 |
Retained earnings (accumulated deficit) |  |  | (30,660,550 | ) |  |  | (32,520,084 | )
Treasury stock at cost |  |  | (148,291 | ) |  |  | (148,291 | )
Accumulated other comprehensive income (loss) |  |  | 1,624,673 |  |  |  | 1,777,112 |
Total Cemtrex stockholders’ equity |  |  | 29,683,054 |  |  |  | 29,351,383 |
Non-controlling interest |  |  | 1,063,121 |  |  |  | 1,077,645 |
Total liabilities and shareholders’ equity |  | $ | 58,235,219 |  |  | $ | 61,190,287 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss)

|  | June 30, 2021 |  |  | June 30, 2020 |  |  | June 30, 2021 |  |  | June 30, 2020 |
|  | For the three months ended |  | For the nine months ended |
|  | June 30, 2021 |  |  | June 30, 2020 |  |  | June 30, 2021 |  |  | June 30, 2020 |
Revenues |  |  | 10,326,431 |  |  |  | 8,440,867 |  |  |  | 28,422,892 |  |  |  | 32,774,797 |
Cost of revenues |  |  | 6,198,715 |  |  |  | 5,161,015 |  |  |  | 16,360,822 |  |  |  | 18,800,355 |
Gross profit |  |  | 4,127,716 |  |  |  | 3,279,852 |  |  |  | 12,062,070 |  |  |  | 13,974,442 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
General and administrative |  |  | 5,670,019 |  |  |  | 5,347,718 |  |  |  | 16,337,200 |  |  |  | 15,380,199 |
Research and development |  |  | 757,966 |  |  |  | 331,936 |  |  |  | 2,033,688 |  |  |  | 1,113,455 |
Total operating expenses |  |  | 6,427,985 |  |  |  | 5,679,654 |  |  |  | 18,370,888 |  |  |  | 16,493,654 |
Operating income/(loss) |  |  | (2,300,269 | ) |  |  | (2,399,802 | ) |  |  | (6,308,818 | ) |  |  | (2,519,212 | )
Other income/(expense) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other income/(expense) |  |  | 3,901,658 |  |  |  | 158,134 |  |  |  | 6,532,590 |  |  |  | 830,251 |
Settlement Agreement - Related Party |  |  | - |  |  |  | - |  |  |  | 3,674,165 |  |  |  | - |
Interest Expense |  |  | (433,009 | ) |  |  | (1,982,101 | ) |  |  | (1,891,026 | ) |  |  | (3,812,921 | )
Total other income/(expense), net |  |  | 3,468,649 |  |  |  | (1,823,967 | ) |  |  | 8,315,729 |  |  |  | (2,982,670 | )
Net loss before income taxes |  |  | 1,168,380 |  |  |  | (4,223,769 | ) |  |  | 2,006,911 |  |  |  | (5,501,882 | )
Income tax benefit/(expense) |  |  | (40,759 | ) |  |  | (7,658 | ) |  |  | (168,190 | ) |  |  | (197,201 | )
Net income/(loss) |  |  | 1,127,621 |  |  |  | (4,231,427 | ) |  |  | 1,838,721 |  |  |  | (5,699,083 | )
Less income in noncontrolling interest |  |  | 29,608 |  |  |  | (35,751 | ) |  |  | (20,813 | ) |  |  | 151,312 |
Net income/(loss) attributable to Cemtrex, Inc. shareholders |  | $ | 1,098,013 |  |  | $ | (4,195,676 | ) |  | $ | 1,859,534 |  |  | $ | (5,850,395 | )
Net income/(loss) |  | $ | 1,127,621 |  |  | $ | (4,231,427 | ) |  | $ | 1,838,721 |  |  | $ | (5,699,083 | )
Other comprehensive income/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation gain/(loss) |  |  | (193,554 | ) |  |  | 154,443 |  |  |  | (234,045 | ) |  |  | 161,460 |
Defined benefit plan actuarial gain/(loss) |  |  | - |  |  |  | - |  |  |  | 87,895 |  |  |  | - |
Comprehensive income/(loss) |  |  | 934,067 |  |  |  | (4,076,984 | ) |  |  | 1,692,571 |  |  |  | (5,537,623 | )
Less comprehensive income/(loss) attributable to noncontrolling interest |  |  | (35,731 | ) |  |  | 41,266 |  |  |  | 14,524 |  |  |  | (118,623 | )
Comprehensive income/(loss) attributable to Cemtrex, Inc. shareholders |  | $ | 969,798 |  |  | $ | (4,118,250 | ) |  | $ | 1,678,047 |  |  | $ | (5,419,000 | )
Income/(loss) Per Share-Basic |  | $ | 0.06 |  |  | $ | (0.38 | ) |  | $ | 0.10 |  |  | $ | (0.82 | )
Income/(loss) Per Share-Diluted |  | $ | 0.06 |  |  | $ | (0.38 | ) |  | $ | 0.10 |  |  | $ | (0.82 | )
Weighted Average Number of Shares-Basic |  |  | 18,711,463 |  |  |  | 10,933,926 |  |  |  | 18,368,274 |  |  |  | 7,161,785 |
Weighted Average Number of Shares-Diluted |  |  | 18,711,463 |  |  |  | 10,933,926 |  |  |  | 18,368,274 |  |  |  | 7,161,785 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity

(Unaudited/Restated)

|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | At cost |  |  | Income(loss) |  |  | Equity |  |  | interest |
|  | Preferred Stock Series 1 |  |  | Preferred Stock Series A |  |  | Preferred Stock Series C |  |  | Common Stock |  |  |  |  |  | Retained |  |  |  |  |  | Accumulated |  |  |  |  |  |  |
|  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Par Value $0.01 |  |  | Additional |  |  | Earnings |  |  | Treasury |  |  | other |  |  | Cemtrex |  |  | Non- |
|  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Paid-in |  |  | (Accumulated |  |  | Stock, |  |  | Comprehensive |  |  | Stockholders’ |  |  | controlling |
|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | At cost |  |  | Income(loss) |  |  | Equity |  |  | interest |
Balance at September 30, 2020, as reported |  |  | 2,156,784 |  |  | $ | 2,157 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | 100,000 |  |  | $ | 100 |  |  |  | 17,622,539 |  |  | $ | 17,623 |  |  | $ | 63,313,336 |  |  | $ | (33,172,690 | ) |  | $ | (148,291 | ) |  | $ | 853,643 |  |  | $ | 30,866,878 |  |  | $ | 1,077,645 |
Adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,091,570 | ) |  |  | 652,606 |  |  |  |  |  |  |  | 923,469 |  |  |  | (1,515,495 | ) |  |  |  |
Balance at September 30, 2020, as restated |  |  | 2,156,784 |  |  | $ | 2,157 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | 100,000 |  |  | $ | 100 |  |  |  | 17,622,539 |  |  | $ | 17,623 |  |  | $ | 60,221,766 |  |  | $ | (32,520,084 | ) |  | $ | (148,291 | ) |  | $ | 1,777,112 |  |  | $ | 29,351,383 |  |  | $ | 1,077,645 |
Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 37,864 |  |  |  | 37,864 |  |  |  |  |
Defined benefit plan actuarial gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  | 16,071 |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | 16,071 |  |  |  |  |
Shares issued to pay accounts payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued to pay accounts payable, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares sold in Securities Purchase Agreements, net of offering costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares sold in Securities Purchase Agreements, net of offering costs, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares granted to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares granted to pay notes payable, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 345,638 |  |  |  | 345 |  |  |  | 407,507 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 407,852 |  |  |  |  |
Shares issued for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued for services, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of treasury stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income in noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares and options surrendered in settelment agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares and options surrendered in settelment agreement, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividends paid in Series 1 preferred shares |  |  | 108,169 |  |  |  | 108 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (108 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  |  |
Net income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | (40,247 | )
Comprehensive income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | 9,617 |
Noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1,692,611 | ) |  |  |  |  |  |  |  |  |  |  | (1,692,611 | ) |  |  |  |
Balance at December 31, 2020 |  |  | 2,264,953 |  |  | $ | 2,265 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | 100,000 |  |  | $ | 100 |  |  |  | 17,968,177 |  |  | $ | 17,968 |  |  | $ | 60,645,236 |  |  | $ | (34,212,695 | ) |  | $ | (148,291 | ) |  | $ | 1,814,976 |  |  | $ | 28,120,559 |  |  | $ | 1,047,015 |
Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (78,521 | ) |  |  | (78,521 | ) |  |  |  |
Defined benefit plan actuarial gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 87,895 |  |  |  | 87,895 |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49,246 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49,246 |  |  |  |  |
Shares issued to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 743,286 |  |  |  | 743 |  |  |  | 1,298,733 |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | 1,299,476 |  |  |  |  |
Income in noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (19,625 | )
Shares and options surrendered in settelment agreement |  |  | (469,949 | ) |  |  | (470 | ) |  |  | (1,000,000.00 | ) |  |  | (1,000 | ) |  |  | (50,000 | ) |  |  | (50 | ) |  |  |  |  |  |  |  |  |  |  | (3,672,645 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,674,165 | ) |  |  |  |
Net income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,454,132 |  |  |  |  |  |  |  |  |  |  |  | 2,454,132 |  |  |  |  |
Balance at March 31, 2021 |  |  | 1,795,004 |  |  | $ | 1,795 |  |  |  | - |  |  | $ | - |  |  |  | 50,000 |  |  | $ | 50 |  |  |  | 18,711,463 |  |  | $ | 18,711 |  |  | $ | 58,320,570 |  |  | $ | (31,758,563 | ) |  | $ | (148,291 | ) |  | $ | 1,824,350 |  |  | $ | 28,258,622 |  |  | $ | 1,027,390 |
Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (199,677 | ) |  |  | (199,677 | ) |  |  |  |
Dividends paid in Series 1 preferred shares |  |  | 90,147 |  |  |  | 90 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (90 | ) |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 45,587 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 45,587 |  |  |  |  |
Shares granted to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 480,509 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 480,509 |  |  |  |  |
Income in noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | 35,731 |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  |  |
Net income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,098,013 |  |  |  |  |  |  |  |  |  |  |  | 1,098,013 |  |  |  |  |
Balance at June 30, 2021 |  |  | 1,885,151 |  |  | $ | 1,885 |  |  |  | - |  |  | $ | - |  |  |  | 50,000 |  |  | $ | 50 |  |  |  | 18,711,463 |  |  | $ | 18,711 |  |  | $ | 58,846,576 |  |  | $ | (30,660,550 | ) |  | $ | (148,291 | ) |  | $ | 1,624,673 |  |  | $ | 29,683,054 |  |  | $ | 1,063,121 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity (Continued)

(Unaudited/Restated)

|  | Preferred Stock Series 1 |  |  | Preferred Stock Series A |  |  | Preferred Stock Series C |  |  | Common Stock Par |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Value $0.01 |  |  |  |  |  | Retained |  |  |  |  |  | Accumulated |  |  |  |  |  |  |
|  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Additional Paid-in |  |  | Earnings (Accumulated |  |  | Treasury Stock, |  |  | other Comprehensive |  |  | Cemtrex Stockholders’ |  |  | Non- controlling |
|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | At cost |  |  | Income(loss) |  |  | Equity |  |  | interest |
Balance at September 30, 2019 |  |  | 2,110,718 |  |  | $ | 2,111 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | - |  |  | $ | - |  |  |  | 3,962,790 |  |  | $ | 3,963 |  |  | $ | 39,337,117 |  |  | $ | (23,676,887 | ) |  | $ | - |  |  | $ | 1,791,153 |  |  | $ | 17,458,457 |  |  | $ | 885,874 |
Foreign currency translation gain |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 582,156 |  |  |  | 582,156 |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |  |  | 100 |  |  |  |  |  |  |  |  |  |  |  | 119,004 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 119,104 |  |  |  |  |
Shares issued to pay accounts payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 18,358 |  |  |  | 18 |  |  |  | 27,520 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 27,538 |  |  |  |  |
Shares sold in Securities Purchase Agreements, net of offering costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 338,393 |  |  |  | 338 |  |  |  | 359,712 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 360,050 |  |  |  |  |
Stock issued to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 105,042 |  |  |  | 105 |  |  |  | 130,147 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 130,252 |  |  |  |  |
Dividends paid in Series 1 preferred shares |  |  | 105,965 |  |  |  | 106 |  |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (106 | ) |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |
Net income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | 194,911 |
Comprehensive income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | (18,429 | )
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (55,618 | ) |  |  |  |  |  |  |  |  |  |  | (55,618 | ) |  |  |  |
Balance at December 31, 2019 |  |  | 2,216,683 |  |  | $ | 2,217 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | 100,000 |  |  | $ | 100 |  |  |  | 4,424,583 |  |  | $ | 4,424 |  |  | $ | 39,973,394 |  |  | $ | (23,732,505 | ) |  | $ | - |  |  | $ | 2,373,309 |  |  | $ | 18,621,939 |  |  | $ | 1,062,356 |
Foreign currency translation gain |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (748,929 | ) |  |  | (748,929 | ) |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 24,104 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 24,104 |  |  |  |  |
Shares sold in Securities Purchase Agreements, net of offering costs |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 847,000 |  |  |  | 847 |  |  |  | 1,160,253 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,161,100 |  |  |  |  |
Stock issued to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,518,045 |  |  |  | 2,519 |  |  |  | 3,499,747 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,502,266 |  |  |  |  |
Shares issued for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 150,000 |  |  |  | 150 |  |  |  | 170,850 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 171,000 |  |  |  |  |
Purchase of treasury stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (190,483 | ) |  |  |  |  |  |  | (190,483 | ) |  |  |  |
Noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | (16,593 | )
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1,599,101 | ) |  |  |  |  |  |  |  |  |  |  | (1,599,101 | ) |  |  |  |
Balance at March 31, 2020 |  |  | 2,216,683 |  |  | $ | 2,217 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | 100,000 |  |  | $ | 100 |  |  |  | 7,939,628 |  |  | $ | 7,940 |  |  | $ | 44,828,348 |  |  | $ | (25,331,606 | ) |  | $ | (190,483 | ) |  | $ | 1,624,380 |  |  | $ | 20,941,896 |  |  | $ | 1,045,763 |
Foreign currency translation gain |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 154,443 |  |  |  | 154,443 |  |  |  |  |
Foreign currency translation gain (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 154,443 |  |  |  | 154,443 |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 24,104 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 24,104 |  |  |  |  |
Shares sold in Securities Purchase Agreements, net of offering costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,458,479 |  |  |  | 5,459 |  |  |  | 10,095,311 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,100,770 |  |  |  |  |
Stock issued to pay notes payable |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2,595,608 |  |  |  | 2,595 |  |  |  | 3,298,811 |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | 3,301,406 |  |  |  |  |
Shares issued for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 270,000 |  |  |  | 270 |  |  |  | 229,730 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 230,000 |  |  |  |  |
Noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | (41,266 | )
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (4,195,676 | ) |  |  |  |  |  |  |  |  |  |  | (4,195,676 | ) |  |  |  |
Net income (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (4,195,676 | ) |  |  |  |  |  |  |  |  |  |  | (4,195,676 | ) |  |  |  |
Balance at June 30, 2020 |  |  | 2,216,683 |  |  | $ | 2,217 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | 100,000 |  |  | $ | 100 |  |  |  | 16,263,715 |  |  | $ | 16,264 |  |  | $ | 58,476,304 |  |  | $ | (29,527,282 | ) |  | $ | (190,483 | ) |  | $ | 1,778,823 |  |  | $ | 30,556,943 |  |  | $ | 1,004,497 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited/Restated)

|  | For the nine months ended June 30, |
Cash Flows from Operating Activities |  | 2021 |  |  | 2020 |
|  | (unaudited) |  |  | (restated) |
Net income/(loss) |  | $ | 1,838,721 |  |  | $ | (5,699,083 | )
Adjustments to reconcile net loss to net cash provided/(used) by operating activities: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 972,186 |  |  |  | 1,343,207 |
Gain on disposal of property and equipment |  |  | 18,583 |  |  |  | 457 |
Amortization of right-of-use assets |  |  | 653,175 |  |  |  | 352,691 |
Change in allowance for doubtful accounts |  |  | (161,101 | ) |  |  | 126 |
Share-based compansation |  |  | 110,904 |  |  |  | 167,312 |
Income tax expense/ (benefit) |  |  | 168,190 |  |  |  | (197,201 | )
Interest expense paid in equity shares |  |  | 818,348 |  |  |  | 2,505,924 |
Accrued interest on notes payable |  |  | 64,748 |  |  |  | 308,748 |
Amortization of original issue discounts on notes payable |  |  | 575,000 |  |  |  | 757,278 |
Gain on marketable securities |  |  | (2,407,841 | ) |  |  | (607,103 | )
Settlement Agreement - Related Party |  |  | (3,674,165 | ) |  |  | - |
Discarge of Paycheck Protection Program Loans |  |  | (3,349,700 | ) |  |  | - |
Changes in operating assets and liabilities net of effects from acquisition |  |  |  |  |  |  |  |
of subsidiaries: |  |  |  |  |  |  |  |
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries: |  |  |  |  |  |  |  |
Accounts receivable |  |  | 1,613,682 |  |  |  | 1,654,383 |
Accounts receivable - related party |  |  | (78,594 | ) |  |  | 5,510 |
Inventory |  |  | (1,875,591 | ) |  |  | (1,384,453 | )
Prepaid expenses and other curent asstets |  |  | (976,050 | ) |  |  | (514,580 | )
Other assets |  |  | 149,778 |  |  |  | (1,017,337 | )
Other liabilities |  |  | 15,019 |  |  |  | (117,667 | )
Accounts payable |  |  | 30,327 |  |  |  | (1,205,851 | )
Operating lease liabilities |  |  | (650,535 | ) |  |  | (296,892 | )
Deposits from customers |  |  | 9,567 |  |  |  | 2,003 |
Accrued expenses |  |  | (78,851 | ) |  |  | 383,230 |
Deferred revenue |  |  | 124,637 |  |  |  | (99,354 | )
Income taxes payable |  |  | (88,987 | ) |  |  | 272,925 |
Net cash used by operating activities |  |  | (6,178,550 | ) |  |  | (3,385,727 | )
Cash Flows from Investing Activities |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (1,113,658 | ) |  |  | (4,541,537 | )
Investment in Virtual Driver Interactive |  |  | (1,075,428 | ) |  |  | - |
Investment in MasterpieceVR |  |  | (500,000 | ) |  |  | - |
Investment in related party |  |  |  |  |  |  | (500,000 | )
Proceeds from sale of marketable securities |  |  | 9,134,159 |  |  |  | 22,720,132 |
Purchase of marketable securities |  |  | (6,290,747 | ) |  |  | (23,479,038 | )
Purchases of treasury stock |  |  | - |  |  |  | (190,483 | )
Note Receivable - Related party |  |  | - |  |  |  | - |
Net cash used by investing activities |  |  | 154,326 |  |  |  | (5,990,926 | )
Cash Flows from Financing Activities |  |  |  |  |  |  |  |
Proceeds from notes payable |  |  | - |  |  |  | 4,485,000 |
Payments on notes payable |  |  | (2,145,257 | ) |  |  | (726,640 | )
Proceeds on bank loans |  |  | - |  |  |  | 5,947,101 |
Payments on bank loans |  |  | (957,186 | ) |  |  | (224,196 | )
Proceeds from Paycheck Protection Program Loans |  |  | 2,942,285 |  |  |  | - |
Proceeds from securities purchase agreements |  |  | - |  |  |  | 12,462,648 |
Payments on capital lease liabilities |  |  | (20,061 | ) |  |  | (13,838 | )
Expenses on securities purchase agreements |  |  | - |  |  |  | (840,728 | )
Revolving line of credit |  |  | - |  |  |  | (425,812 | )
Net cash provided/(used) by financing activities |  |  | (180,219 | ) |  |  | 20,663,535 |
Effect of currency translation |  |  | (298,265 | ) |  |  | 128,771 |
Net increase in cash, cash equivalents, and restricted cash |  |  | (6,204,443 | ) |  |  | 11,286,882 |
Cash, cash equivalents, and restricted cash at beginning of period |  |  | 21,072,859 |  |  |  | 2,858,085 |
Cash, cash equivalents, and restricted cash at end of period |  |  | 14,570,151 |  |  | $ | 14,273,738 |
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |
Cash and equivalents |  | $ | 12,879,278 |  |  | $ | 12,939,493 |
Restricted cash |  |  | 1,690,873 |  |  |  | 1,334,245 |
Total cash, cash equivalents, and restricted cash |  | $ | 14,570,151 |  |  | $ | 14,273,738 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(Unaudited/Restated)

Supplemental Disclosure of Cash Flow Information: |  |  |  |  |  |  |  |
Cash paid during the period for interest |  | $ | 432,930 |  |  | $ | 240,971 |
Cash paid during the period for income taxes |  | $ | 88,987 |  |  | $ | 75,724 |
Supplemental Schedule of Non-Cash Investing and Financing Activities |  |  |  |  |  |  |  |
Investment in Virtual Driver Interactive |  | $ | 439,774 |  |  | $ | - |
Stock issued to pay for products and/or services |  | $ | - |  |  | $ | 428,538 |
Stock issued to pay notes payable |  | $ | 2,187,837 |  |  | $ | 6,933,924 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

8

Cemtrex Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 – ORGANIZATION AND PLAN OF OPERATIONS

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry technology company. The Company has expanded in a wide range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

The Company continuously assesses the composition of its portfolio businesses to ensure it is aligned with its strategic objectives and positioned to maximize growth and return in the coming years. During fiscal 2018, the Company made a strategic decision to exit its Electronics Manufacturing group by selling all companies in that business segment on August 15, 2019. Accordingly, the Company has reported the results of the Electronics Manufacturing business as discontinued operations in the Consolidated Statements of Operations and in the Consolidated Balance Sheets. These changes have been applied for all periods presented. During fiscal 2019, the Company also reached a strategic decision to exit the environmental products business, which was part of the Industrial Services Segment.

Now the Company has two business segments, consisting of (i) Advanced Technologies (AT) and (ii) Industrial Services (IS).

Advanced Technologies (AT)

Cemtrex’s Advanced Technologies segment delivers cutting-edge technologies in the Internet of Things (IoT) and Smart Devices, such as the SmartDesk. Through the Company’s advanced engineering and product design, the Company delivers Virtual Reality (VR) and Augmented Reality (AR) solutions that provide higher productivity, progressive design and impactful experiences for consumer products, and various commercial and industrial applications. The Company is in the process of developing its own virtual reality applications for commercialization over the next couple years.

The AT business segment also includes the Company’s majority owned subsidiary, Vicon Industries, which provides end-to-end security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides cutting edge, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

Industrial Services (IS)

Cemtrex’s IS segment, offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. We are a leading provider of reliability-driven maintenance and contracting solutions for the machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

9

Acquisition of Virtual Driver Interactive

On October 26, 2020, the company acquired Virtual Driver Interactive (“VDI”), a California based provider of innovative driver training simulation solutions for a purchase price of $1,339,774 plus contingent consideration of $175,428.

For over 10 years, VDI has been known for its effective and engaging driver training systems, designed for users of all ages and skill levels. The Company offers comprehensive training for new teen and novice drivers, along with advanced training for corporate fleets and truck drivers. VDI’s wide range of training courses and system options provide customers with highly portable, affordable and effective solutions, all while focusing on the dangers of distracted driving. Result for VDI will be reported under the AT segment.

The Company paid $900,000 in cash and issued a Note payable in the amount of $439,774. This note carries interest of 5% and is payable in two installments of $239,774 plus accumulated interest on October 26, 2021, and $200,000 plus accumulated interest on October 26, 2022. Additionally, the Company paid contingent consideration of $175,428 in May 2021. There is no further contingent consideration specified in the purchase agreement. The Company has accounted for this acquisition as a business combination and is in the process of calculating the allocation of purchase price. All amounts paid have been included in goodwill in the accompanying condensed consolidated balance sheet.

Strategic Investment

On November 13, 2020, Cemtrex made a $500,000 investment via a simple agreement for future equity(“SAFE”) in MasterpieceVR. The SAFE provides that the Company will automatically receive shares of the entity based on the conversion rate of future equity rounds up to a valuation cap, as defined. MasterpieceVR is a software company that is developing software for content creation using virtual reality. The investment is included in other assets in the accompanying balance sheet and the Company accounts for this investment using the fair value method. No impairment has been recorded for the three and nine months ended June 30, 2021.

Potential Impacts of COVID-19 on our Business

The current COVID-19 pandemic has impacted our business operations and the results of our operations in this fiscal year, primarily with delays in expected orders by many customers and new product development. Overall bookings level in both business segments have been impacted. In addition, due to delays in certain supply chain areas, the expected launch times of our new products and new versions of existing products have been delayed for several months. We are also starting to see the costs of certain components that are facing shortages, increase in price which may affect gross margins.

The broader implications of COVID-19 on our results from operations going forward remains uncertain. The COVID-19 pandemic has the potential to cause adverse effects to our customers, suppliers or business partners in locations that have or will experience more pronounced disruptions, which could result in a reduction to future revenue and manufacturing output as well as delays in our new product development activities.

The extent of the pandemic’s effect on our operational and financial performance will depend in large part on future developments, which cannot be reasonably estimated at this time. Future developments include the duration, scope and severity of the pandemic, the actions taken to contain or mitigate its impact both within and outside the jurisdictions where we operate, the impact on governmental programs and budgets, the development of treatments or vaccines, and the resumption of widespread economic activity. Due to the inherent uncertainty of the unprecedented and rapidly evolving situation, we are unable to predict with any confidence the likely impact of the COVID-19 pandemic on our future operations.

10

NOTE 2 – INTERIM STATEMENT PRESENTATION

Basis of Presentation and Use of Estimates

The accompanying unaudited condensed consolidated financial information should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the year ended September 30, 2020, of Cemtrex Inc.

The accompanying condensed consolidated balance sheet has been derived from the audited consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the year ended September 30, 2020, adjusted and restated as further discussed in Note 2 of these financial statements. Additionally, the Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss), the Condensed Consolidated Statement of Stockholders’ Equity, the Condensed Consolidated Statements of Cash Flows, and notes to the financial statements related to the results of the three- and nine-month periods ended June 30, 2020, have been restated.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the Unites States (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X pursuant to the requirements of the U.S. Securities and Exchange Commission (‘SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company’s management. The Company evaluates its estimates and assumptions on an ongoing basis.

The condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, Cemtrex Advanced Technologies Inc., Cemtrex Ltd., Cemtrex Technologies Pvt. Ltd., Griffin Filters, LLC, Cemtrex XR Inc., and Advanced Industrial Services, Inc. and the Company’s majority owned subsidiary Vicon Industries, Inc. and its subsidiaries, Telesite USA, IQInVision, Vicon Industries Ltd., and Vicon Systems, Ltd. All inter-company balances and transactions have been eliminated in consolidation.

Restatement of Financial Statements

Background

On February 23, 2021, Cemtrex’s Board of Directors determined that certain transactions between Cemtrex Inc. and First Commercial, a company owned by former Executive Director, former Controlling Shareholder and former CFO, Aron Govil, were incorrectly handled and accounted for.

The total amount of disputed transfers was approximately $7,100,000 and occurred in fiscal year 2017 in the amount of $5,600,000 and in fiscal year 2018 in the amount of $1,500,000. Cemtrex did not find any other such transfers during this period or thereafter, upon further review of the Company’s records.j

Upon the Company’s investigation into this matter, the Company has determined that there were inaccuracies in the Company’s financial statements. The financials for the periods 2017 and 2018 were incorrect corresponding to the amounts that were incorrectly accounted for, and subsequent years were affected by the roll forward effects of these entries. The Company found unsupported advertising expenses in the amount of approximately $400,000 on Cemtrex Inc’s income statement for fiscal year 2018 and found that approximately $5,700,000 of intangible assets and $975,000 of research and development expenses, as translated at from Indian Rupee at the time, were recorded on Cemtrex India’s financial statements in fiscal year 2018 and could not be substantiated. The total amount of unsubstantiated transfers recorded by Cemtrex India, and the unsupported advertising expense recorded by Cemtrex, Inc. sums to $7,100,000, corresponding with the total amount in question regarding First Commercial transfers during fiscal years 2017 and 2018.

11

As part of the restatement investigation, it was determined that the Company did not follow GAAP in the treatment of its Series 1 Preferred dividends. The Company currently has a deficit in retained earnings and in accordance with guidance has reversed the accrual for dividends payable and placed the amount of the accrual back into retained earnings.

Position and Adjusting Entries

The Company has determined that these transactions are not material in the years that they occurred and conclude that prior financial reports can be relied upon. The Company’s determination is based on the following: The adjustments do not cause any changes to the previously reported cash and debt balances as of the end of each of the periods in FY 2019 and 2020. The adjustments also do not cause any changes to revenues in any of the prior periods. In addition, the Company expects to maintain compliance with its debt covenants based on a preliminary review of the covenants for all the impacted periods. The Company has also determined that the adjustments have little effect on the trend of earnings over the last three fiscal years. In 2017 the operations of the Company were vastly different with both the environmental and circuit board manufacturing segments accounting for approximately 75% of revenues. These businesses are now either sold or discontinued. The current reported 2017 financial statements of the Company do not give an accurate representation of the Company today because only 16% of the $120M business operations are still a part of current operations.

The table below represents the balances of the affected accounts on the Condensed Consolidated Balance Sheets as of September 30, 2020, the Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss) for the three and nine months ended June 30, 2020, Condensed Consolidated Statement of Stockholders’ Equity, and the Condensed Consolidated Statements of Cash Flows for the nine months ended June 30, 2020.

Condensed Consolidated Balance Sheets

SCHEDULE OF CONDENSED CONSOLIDATED BALANCE SHEETS

|  | Balance as reported on September 30, 2020 |  |  | Adjustment of net value of intangible assets |  |  | Cumulative effect of derecognition of expenses |  |  | Loss on amounts transferred to First Commercial |  |  | Restatement on Dividends |  |  | Cumulative effect of currency translation |  |  | Adjusted balance at September 30, 2020
Property and equipment, net |  | $ | 9,558,936 |  |  | $ | (2,597,185 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $6,961,751
Series 1 preferred stock dividends payable |  | $ | 1,081,690 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (1,081,690 | ) |  |  |  |  |  | $-
Additional paid-in capital |  | $ | 63,313,336 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (3,091,570 | ) |  |  |  |  |  | $60,221,766
Retained earnings (accumulated deficit) |  | $ | (33,172,690 | ) |  |  |  |  |  | $ | 3,579,346 |  |  | $ | (7,100,000 | ) |  | $ | 4,173,260 |  |  |  |  |  |  | $(32,520,084)
Accumulated other comprehensive income |  | $ | 853,643 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 923,469 |  |  | $1,777,112

Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss)

SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME/(LOSS)

|  | For the three months ended |
|  | June 30, 2020 |
|  | Previously reported |  |  | Adjustments |  |  | Adjusted |
Net Income income/(loss) attributable to Cemtrex, Inc. shareholders |  | $ | (4,454,617 | ) |  | $ | 258,941 |  |  | $ | (4,195,676 | )
Foreign currency translation gain/(loss) |  | $ | 310,797 |  |  | $ | (156,354 | ) |  | $ | 154,443 |
Loss Per Share-Basic |  | $ | (0.41 | ) |  | $ | 0.02 |  |  | $ | (0.38 | )
Loss Per Share-Diluted |  | $ | (0.41 | ) |  | $ | 0.02 |  |  | $ | (0.38 | )

|  | For the nine months ended |
|  | June 30, 2020 |
|  | Previously reported |  |  | Adjustments |  |  | Adjusted |
Net loss available to Cemtrex, Inc. shareholders |  | $ | (6,658,086 | ) |  | $ | 807,691 |  |  | $ | (5,850,395 | )
Foreign currency translation gain |  | $ | 153,420 |  |  | $ | 8,040 |  |  | $ | 161,460 |
Loss Per Share-Basic |  | $ | (0.93 | ) |  | $ | 0.11 |  |  | $ | (0.82 | )
Loss Per Share-Diluted |  | $ | (0.93 | ) |  | $ | 0.11 |  |  | $ | (0.82 | )

12

Condensed Consolidated Statement of Stockholders’ Equity

SCHEDULE OF CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

|  | For the nine months ended |
|  | June 30, 2020 |
|  | Previously reported |  |  | Adjustments |  |  | Adjusted |
Retained earnings (accumulated deficit) at September 30, 2019 |  | $ | (20,067,685 | ) |  | $ | (3,609,202 | ) |  | $ | (23,676,887 | )
Net income/(loss) |  | $ | (8,744,636 | ) |  | $ | 2,894,241 |  |  | $ | (5,850,395 | )
Retained earnings (accumulated deficit) at June 30, 2020 |  | $ | (28,812,321 | ) |  | $ | (714,961 | ) |  | $ | (29,527,282 | )
Accumulated other comprehensive income/(loss)at September 30, 2019 |  | $ | 796,004 |  |  | $ | 995,149 |  |  | $ | 1,791,153 |
Comprehensive income/(loss) |  | $ | 153,420 |  |  | $ | 8,040 |  |  | $ | 161,460 |
Accumulated other comprehensive income/(loss) at June 30, 2020 |  | $ | 949,424 |  |  | $ | 829,399 |  |  | $ | 1,778,823 |
Additional paid-in capital |  | $ | 60,543,674 |  |  | $ | (2,067,370 | ) |  | $ | 58,476,304 |

Condensed Consolidated Statements of Cash Flows

SCHEDULE OF CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

|  | For the nine months ended |
|  | June 30, 2020 |
|  | Previously reported |  |  | Adjustments |  |  | Adjusted |
Net loss |  | $ | (6,506,774 | ) |  | $ | 807,691 |  |  | $ | (5,699,083 | )
Depreciation and amortization |  | $ | 2,158,938 |  |  | $ | (815,731 | ) |  | $ | 1,343,207 |
Net cash used by operating activities |  | $ | (3,377,687 | ) |  | $ | (8,040 | ) |  | $ | (3,385,727 | )
Effect of currency translation |  | $ | 120,731 |  |  | $ | 8,040 |  |  | $ | 128,771 |

On February 26, 2021, the Company entered into a Settlement Agreement and Release with Aron Govil regarding these transactions.

As part of the Settlement Agreement, Mr. Govil was required to pay the Company consideration with a total value of $7,100,000 (the “Settlement Amount”) by entering into the Agreement. The Settlement Amount was satisfied in a combination of Mr. Govil forfeiting certain Preferred Stock and outstanding options and executing a secured note in the amount of $1,533,280. The Independent Board of Directors in coordination with Management concluded the settlement represented fair value.

In March 2021, Mr. Govil returned to the Company 1,000,000 shares of Series A Preferred Stock, 50,000 Shares of Series C Preferred Stock, 469,949 shares of Series 1 Preferred Stock, and forfeited all outstanding options to purchase shares of commons stock (collectively, the “Securities”). For the purposes of accounting recognition, the Company determined the fair value of the Series A, Series C, and Series 1 Preferred stock based on the closing trading value of the Series 1 Preferred Stock on the date of the agreement. The options surrendered were valued using the Black-Scholes option pricing model.

The Company recognized the gain with respect to the surrendered Securities during this reporting period. The gain of $3,674,165 is reported as Settlement Agreement - Related Party on the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss).

As discussed above, Mr. Govil also executed a secured promissory note (the “Note”) in the amount of $1,533,280. The Note matures and is due in full in two years and bears interest at 9% per annum and is secured by all of Mr. Govil’s assets. Mr. Govil also agreed to sign an affidavit confessing judgment in the event of a default on the Note. While the Company believes the note is fully collectible, in accordance with ASC 450-30, Gain Contingencies, the Company determined the gain will not be recognized until the note is paid. Accordingly, the note and associated gain is not presented on the Company’s Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss).

Accounting Pronouncements

Significant Accounting Policies

Note 2 of the Notes to Consolidated Financial Statements, included in the annual report on Form 10-K for the year ended September 30, 2020, includes a summary of the significant accounting policies used in the preparation of the consolidated financial statements.

13

Recently Issued Accounting Standards

In December 2019, the FASB issued amended guidance, Simplifying the Accounting for Income Taxes, to remove certain exceptions to the general principles from ASC 740 - Income Taxes, and to improve consistent application of U.S. GAAP for other areas of ASC 740 by clarifying and amending existing guidance. The guidance is effective for the Company on October 1, 2021; early adoption is permitted. The Company is currently evaluating the effect the guidance will have on its consolidated financial statement disclosures, results of operations and financial position.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU No. 2020-04”). The update provides optional guidance for a limited period to ease the potential burden in accounting for (or recognizing the effects of) contract modifications on financial reporting caused by reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020, through December 31, 2022. The Company adopted this guidance in the second quarter of 2020. The adoption of this guidance had no impact on the Company’s Condensed Consolidated Financial Statements or the related disclosures.

NOTE 3 – LOSS PER COMMON SHARE

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. For the three and nine months ended June 30, 2021, and 2020, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:

SCHEDULE OF EXCLUDED FROM COMPUTATION OF DILUTED NET LOSS PER COMMON SHARE AS ANTI-DILUTIVE

|  | For the three months ended |  |  | For the nine months ended |
|  | June 30, |  |  | June 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Warrants to purchase shares |  |  | 433,965 |  |  |  | 433,965 |  |  |  | 433,965 |  |  |  | 433,965 |
Options |  |  | 1,383,965 |  |  |  | 1,145,871 |  |  |  | 1,383,965 |  |  |  | 1,204,329 |

NOTE 4 – SEGMENT INFORMATION

The Company reports and evaluates financial information for two segments: Advanced Technologies (AT) segment, and the Industrial Services (IS) segment. The AT segment develops smart devices and provides progressive design and development solutions to create impactful experiences for mobile, web, virtual and augmented reality, wearables and television as well as providing cutting edge, mission critical security and video surveillance. The IS segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers in USA in industries such as: manufacturing, steel, printing, construction, & petrochemical.

14

The following tables summarize the Company’s segment information:

SCHEDULE OF SEGMENT INFORMATION

|  | For the three months ended |  |  | For the nine months ended |
|  | June 30, |  |  | June 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Revenues from external customers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 5,845,958 |  |  | $ | 4,977,424 |  |  | $ | 16,006,241 |  |  | $ | 18,389,057 |
Industrial Services |  | $ | 4,480,473 |  |  |  | 3,463,443 |  |  |  | 12,416,651 |  |  |  | 14,385,740 |
Total revenues |  | $ | 10,326,431 |  |  | $ | 8,440,867 |  |  | $ | 28,422,892 |  |  | $ | 32,774,797 |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 2,693,677 |  |  | $ | 1,837,957 |  |  | $ | 7,686,875 |  |  | $ | 8,712,543 |
Industrial Services |  |  | 1,434,039 |  |  |  | 1,441,895 |  |  |  | 4,375,195 |  |  |  | 5,261,899 |
Total gross profit |  | $ | 4,127,716 |  |  | $ | 3,279,852 |  |  | $ | 12,062,070 |  |  | $ | 13,974,442 |
Operating loss |  |  |  |  |  |  | (restated) |  |  |  |  |  |  |  | (restated) |
Advanced Technologies |  | $ | (1,650,221 | ) |  | $ | (1,595,405 | ) |  | $ | (5,185,944 | ) |  | $ | (1,686,680 | )
Industrial Services |  |  | (650,048 | ) |  |  | (804,397 | ) |  |  | (1,122,874 | ) |  |  | (832,532 | )
Total operating loss |  | $ | (2,300,269 | ) |  | $ | (2,399,802 | ) |  | $ | (6,308,818 | ) |  | $ | (2,519,212 | )
Other income/(expense) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 4,955,782 |  |  | $ | (1,795,637 | ) |  | $ | 5,666,112 |  |  | $ | (2,868,033 | )
Industrial Services |  |  | (1,487,133 | ) |  |  | (28,330 | ) |  |  | 2,649,617 |  |  |  | (114,637 | )
Total other expense |  | $ | 3,468,649 |  |  | $ | (1,823,967 | ) |  | $ | 8,315,729 |  |  | $ | (2,982,670 | )
Depreciation and Amortization |  |  |  |  |  |  | (restated) |  |  |  |  |  |  |  | (restated) |
Advanced Technologies |  | $ | 103,177 |  |  | $ | 114,151 |  |  | $ | 308,755 |  |  | $ | 212,088 |
Industrial Services |  |  | 189,005 |  |  |  | 358,128 |  |  |  | 663,431 |  |  |  | 1,139,159 |
Total depreciation and amortization |  | $ | 292,182 |  |  | $ | 472,279 |  |  | $ | 972,186 |  |  | $ | 1,351,247 |

|  |  |  |  | September 30, |
|  | June 30, |  |  | 2020 |
|  | 2020 |  |  | (restated) |
Identifiable Assets |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 31,726,862 |  |  | $ | 36,732,018 |
Industrial Services |  |  | 17,640,536 |  |  |  | 15,590,448 |
Discontinued operations |  |  | 8,867,821 |  |  |  | 8,867,821 |
Total Assets |  | $ | 58,235,219 |  |  | $ | 61,190,287 |

NOTE 5 – FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:

Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include cash equivalents, banker’s acceptances, trading securities investments and investment funds. We measure trading securities investments and investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions.

15

Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified contractual term, a Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee’s ability to continue as a going concern.

The Company’s fair value assets at June 30, 2021, are as follows.

SCHEDULE OF FAIR VALUE OF ASSETS

|  | Quoted Prices in Active |  |  | Significant |  |  |  |  |  |  |
|  | Markets for |  |  | Other |  |  | Significant |  |  | Balance |
|  | Identical |  |  | Observable |  |  | Unobservable |  |  | as of |
|  | Assets |  |  | Inputs |  |  | Inputs |  |  | June 30, |
|  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | 2021 |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in marketable securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(included in short-term investments) |  | $ | 452,175 |  |  | $ | - |  |  | $ | - |  |  | $ | 452,175 |
Investment in MasterpieceVR |  |  |  |  |  |  |  |  |  | $ | 500,000 |  |  | $ | 500,000 |
(included in Other assets) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | $ | 452,175 |  |  | $ | - |  |  | $ | 500,000 |  |  | $ | 952,175 |

NOTE 6 – RESTRICTED CASH

A subsidiary of the Company participates in a consortium in order to self-insure group care coverage for its employees. The plan is administrated by Benecon Group and the Company makes monthly deposits in a trust account to cover medical claims and any administrative costs associated with the plan. These funds, as required by the plan are restricted in nature and amounted to $1,533,458 as of June 30, 2021. Additionally, the Company has a standby letter of credit for deposit on a building lease and payable against. a money market account, the amount of the standby letter of credit is $157,415.

NOTE 7 – ACCOUNTS RECEIVABLE, NET

Accounts receivables, net consist of the following:

SCHEDULE OF ACCOUNTS RECEIVABLE, NET

|  | June 30, |  |  | +September 30, |
|  | 2021 |  |  | 2020 |
Accounts receivable |  | $ | 5,413,963 |  |  | $ | 7,027,645 |
Allowance for doubtful accounts |  |  | (179,747 | ) |  |  | (340,848 | )
Accounts receivables, net, total |  | $ | 5,234,216 |  |  | $ | 6,686,797 |

Accounts receivable include amounts due for shipped products and services rendered.

Allowance for doubtful accounts include estimated losses resulting from the inability of our customers to make required payments.

16

NOTE 8 – INVENTORY, NET

Inventory, net, consist of the following:

SCHEDULE OF INVENTORY, NET

|  | June 30, |  |  | September 30, |
|  | 2021 |  |  | 2020 |
Raw materials |  | $ | 2,309,734 |  |  | $ | 3,959,888 |
Work in progress |  |  | 779,929 |  |  |  | 995,184 |
Finished goods |  |  | 6,751,717 |  |  |  | 6,413,927 |
Inventory, gross |  |  | 9,841,380 |  |  |  | 11,368,999 |
Less: Allowance for inventory obsolescence |  |  | (1,171,983 | ) |  |  | (4,575,193 | )
Inventory –net of allowance for inventory obsolescence |  | $ | 8,669,397 |  |  | $ | 6,793,806 |

NOTE 9 – PROPERTY AND EQUIPMENT

Property and equipment are summarized as follows:

SUMMARY OF PROPERTY AND EQUIPMENT

|  | June 30, |  |  | September 30, |
|  | 2021 |  |  | 2020 |
|  |  |  |  | (restated) |
Land |  | $ | 790,373 |  |  | $ | 790,373 |
Building and leasehold improvements |  |  | 3,962,225 |  |  |  | 3,875,796 |
Furniture and office equipment |  |  | 687,055 |  |  |  | 621,790 |
Computers and software |  |  | 346,051 |  |  |  | 264,940 |
Trade show display |  |  | 89,330 |  |  |  | 89,330 |
Machinery and equipment |  |  | 14,675,127 |  |  |  | 13,668,263 |
|  |  | 20,550,161 |  |  |  | 19,310,492 |
Less: Accumulated depreciation |  |  | (13,313,406 | ) |  |  | (12,348,741 | )
Property and equipment, net |  | $ | 7,236,755 |  |  | $ | 6,961,751 |

Depreciation expense for the three and nine months ended June 30, 2021, and 2020 were $292,182 and $972,186, and $472,279 and $1,351,247, respectively.

NOTE 10 – LEASES

ASC 842, “Leases”, requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at either the effective date (the “effective date method”) or the beginning of the earliest period presented (the “comparative method”) using a modified retrospective approach. Under the effective date method, the Company’s comparative period reporting is unchanged. In contrast, under the comparative method, the Company’s date of initial application is the beginning of the earliest comparative period presented, and the Topic 842 transition guidance is then applied to all comparative periods presented. Further, under either transition method, the standard includes certain practical expedients intended to ease the burden of adoption. The Company adopted ASC 842 October 1, 2019, using the effective date method and elected certain practical expedients allowing the Company not to reassess:

| ● | whether expired or existing contracts contain leases under the new definition of a lease;
| ● | lease classification for expired or existing leases; and
| ● | whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.

17

The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.

The Company entered into a financing lease for a single vehicle in the Industrial services segment with a term of 3 years. The Company enters into operating leases for its facilities in New York, United Kingdom, and India, as well as for vehicles for use in our Industrial Services segment. The operating lease terms range from 2 to 7 years. The Company excluded the renewal option on its applicable facility leases from the calculation of its right-of-use assets and lease liabilities.

Finance and operating lease liabilities consist of the following:

SUMMARY OF FINANCE AND OPERATING LEASE LIABILITIES

|  | June 30, |  |  | September 30, |
|  | 2021 |  |  | 2020 |
Lease liabilities - current |  |  |  |  |  |  |  |
Finance leases |  | $ | - |  |  | $ | 20,061 |
Operating leases |  |  | 840,016 |  |  |  | 700,975 |
|  |  | 840,016 |  |  |  | 721,036 |
Lease liabilities - net of current portion |  |  |  |  |  |  |  |
Finance leases |  | $ | - |  |  | $ | - |
Operating leases |  |  | 2,261,148 |  |  |  | 2,027,406 |
|  | $ | 2,261,148 |  |  | $ | 2,027,406 |

A reconciliation of undiscounted cash flows to finance and operating lease liabilities recognized in the condensed consolidated balance sheet at June 30, 2021, is set forth below:

SCHEDULE OF RECONCILIATION OF UNDISCOUNTED CASH FLOWS TO FINANCE AND OPERATING LEASE LIABILITIES

Years ending September 30, |  | Finance leases |  |  | Operating Leases |  |  | Total |
2021 |  |  | - |  |  |  | 236,899 |  |  |  | 236,899 |
2022 |  |  | - |  |  |  | 895,590 |  |  |  | 895,590 |
2023 |  |  | - |  |  |  | 712,413 |  |  |  | 712,413 |
2024 |  |  | - |  |  |  | 576,687 |  |  |  | 576,687 |
2025 |  |  | - |  |  |  | 552,884 |  |  |  | 552,884 |
2026 & Thereafter |  |  | - |  |  |  | 621,099 |  |  |  | 621,099 |
Undiscounted lease payments |  |  | - |  |  |  | 3,595,572 |  |  |  | 3,595,572 |
Amount representing interest |  |  | - |  |  |  | (494,408 | ) |  |  | (494,408 | )
Discounted lease payments |  | $ | - |  |  | $ | 3,101,164 |  |  | $ | 3,101,164 |

18

Additional disclosures of lease data are set forth below:

SCHEDULE OF LEASE COSTS

|  | Nine months ended |
|  | June 30, 2021 |  |  | March 31, 2020 |
Lease costs: |  |  |  |  |  |  |  |
Finance lease costs: |  |  |  |  |  |  |  |
Depreciation of finance lease assets |  | $ | 17,184 |  |  | $ | 11,456 |
Interest on lease liabilities |  |  | 88 |  |  |  | 416 |
Operating lease costs: |  |  |  |  |  |  |  |
Amortization of right-of-use assets |  |  | 653,175 |  |  |  | 275,822 |
Interest on lease liabilities |  |  | 56,927 |  |  |  | 20,375 |
Total lease cost |  | $ | 727,374 |  |  | $ | 308,069 |
Other information: |  |  |  |  |  |  |  |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |  |
Operating leases |  | $ | 650,535 |  |  | $ | 296,892 |
Finance leases |  |  | 28,535 |  |  |  | 13,838 |
|  | $ | 679,070 |  |  | $ | 310,730 |
Weighted-average remaining lease term - finance leases (months) |  |  | 3 |  |  |  | 13 |
Weighted-average remaining lease term - operating leases (months) |  |  | 58 |  |  |  | 73 |
Weighted-average discount rate - finance leases |  |  | 3.63 | % |  |  | 6.95 | %
Weighted-average discount rate - operating leases |  |  | 6.85 | % |  |  | 6.98 | %

The Company used the rate implicit in the lease, where known, or its incremental borrowing rate as the rate used to discount the future lease payments.

NOTE 11 – PREPAID AND OTHER CURRENT ASSETS

On June 30, 2021, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $397,056, other current assets of $1,767,311. On September 30, 2020, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $101,308, and other current assets of $1,087,009.

NOTE 12 - OTHER ASSETS

As of June 30, 2021, the Company had other assets of $1,094,429 which was comprised of rent security of $248,160, a strategic investment in MasterpieceVR of $500,000, and other assets of $346,269. As of September 30, 2020, the Company had other assets of $744,207 which was comprised of rent security deposits of $294,553 and other assets of $449,654.

NOTE 13 – RELATED PARTY TRANSACTIONS

On August 31, 2019, the Company entered into an Asset Purchase Agreement for the sale of Griffin Filters, LLC to Ducon Technologies, Inc., which Aron Govil, the Company’s Founder and Former CFO, is President, for total consideration of $550,000. As of June 30, 2021, and September 30, 2020, there was $1,515,820 and $1,432,209 in receivables due from Ducon Technologies, Inc., respectively. At June 30, 2021, $500,000 of the balance due is for the sale of Griffin, which was due in February 2021, and the remaining balance are various receivables with various due dates within the next fiscal year. The Company is currently negotiating a payment agreement surrounding all these amounts due.

Please see Note 2 for further transactions relating to Aron Govil.

19

NOTE 14 – LINES OF CREDIT AND LONG-TERM LIABILITIES

Lines of credit

The Company currently has a line of credit with Fulton Bank for $3,500,000. The line carries an interest of LIBOR plus 2.00% per annum (2.09% as of June 30, 2021). At June 30, 2021, there was no outstanding balance on this line of credit.

Loans payable to bank

On December15, 2015, the Company acquired a loan from Fulton Bank in the amount of $5,250,000 in order to fund the purchase of Advanced Industrial Services, Inc. $5,000,000 of the proceeds went to direct purchase of AIS. This loan carries interest of LIBOR plus 2.25% per annum (2.34% as of June 30, 2021) and is payable on December 15, 2022. This loan carries loan covenants which the Company was in compliance with as of June 30, 2021.

On December15, 2015, the Company acquired a loan from Fulton Bank in the amount of $620,000 in order to fund the operations of Advanced Industrial Services, Inc. This loan carries interest of LIBOR plus 2.00% per annum (2.09% as of June 30, 2021) and was fully paid on December 15, 2020.

On May 1, 2018, the Company acquired a loan from Fulton Bank in the amount of $400,000 in order to fund new equipment for Advanced Industrial Services, Inc. This loan carries interest of LIBOR plus 2.00% per annum (2.09% as of June 30, 2021) and is payable on May 1, 2023. This loan carries loan covenants which the Company was in compliance with as of June 30, 2021.

On January 28, 2020, the Company acquired a loan from Fulton Bank in the amount of $360,000 in order to fund new equipment for Advanced Industrial Services, Inc. This loan carries interest of LIBOR plus 2.25% per annum (2.44% as of June 30, 2021) and is payable on May 1, 2023. This loan carries loan covenants which the Company was in compliance with as of June 30, 2021.

Notes payable

On December 23, 2019, the Company, issued a note payable to an independent private lender in the amount of $1,725,000. This note carries interest of 8% and matures on June 23, 2021. After deduction of an original issue discount of $225,000 and legal fees of $5,000, the Company received $1,495,000 in cash. This note was satisfied on November 2, 2020.

On April 24, 2020, the Company, issued a note payable to an independent private lender in the amount of $1,725,000. This note carries interest of 8% and matures on October 24, 2021. After deduction of an original issue discount of $225,000 and legal fees of $5,000, the Company received $1,495,000 in cash. This note was satisfied on January 21, 2021.

On September 30, 2020, the Company, issued a note payable to an independent private lender in the amount of $4,605,000. This note carries interest of 8% and matures on March 30, 2022. After deduction of an original issue discount of 600,000 and legal fees of $5,000, the Company received $4,000,000 in cash.

On March 3, 2020, Vicon, a subsidiary of the Company amended the $5,600,000 Term Loan Agreement with NIL Funding Corporation (“NIL”). Upon closing, $500,000 of outstanding borrowings were repaid to NIL, additionally, another $500,000 is to be paid in one year. The Agreement requires monthly payments of accrued interest that began on October 1, 2018. This note carries interest of 8.85% and matures on March 30, 2022. This note carries loan covenants which the Company is in compliance with as of June 30, 2021.

Mortgage Payable

On January 28, 2020, the Company’s subsidiary, Advanced Industrial Services, Inc., completed the purchase of two buildings for a total purchase price of $3,381,433. The Company paid $905,433 in cash and acquired a mortgage from Fulton Bank in the amount of $2,476,000. This mortgage carries interest of LIBOR plus 2.50% per annum (2.59% as of June 30, 2021) and is payable on January 28, 2040. This loan carries loan covenants similar to covenants on The Company’s other loans from Fulton Bank. As of June 30, 2021, the Company was in compliance with these covenants.

20

Paycheck Protection Program Loans

In April and May of 2020, the Company and its subsidiaries applied for and were granted $3,471,100 in Paycheck Protection Program loans under the CARES Act. These loans bear interest of 1% and mature in two years. The Company will apply for and fully expects these loans to be forgiven under the provisions of the CARES Act and any subsequent legislation that may be applicable. These loans are recorded under Paycheck Protection Program Loans on our Condensed Consolidated Balance Sheet as of September 30, 2020, net of the short-term portion of $710,046. In April and June of 2021 $3,156,700 and $193,000 of these loans were forgiven and included in other income on the consolidated statement of operations and comprehensive income (loss).

On January 24, 2021, and April 17, 2021, subsidiaries of the company received additional $1,970,785 and $971,500, respectively, of Paycheck Protection Program funds as part of the second Paycheck Protection Program for which the subsidiary qualifies due to the decrease in revenues. These loans bear interest of 1% and mature in five years.

NOTE 15 – STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue 10,000,000 shares of Preferred Stock, $0.001 par value. As of June 30, 2021, and September 30, 2020, there were 1,935,151 and 3,256,784 shares issued and outstanding, respectively.

Series 1 Preferred Stock

On March 30, 2020, the Company amended the Certificate of Designation (the “Amended Certificate of Designation”) for our Series 1 Preferred Stock (the “Series 1 Stock”). The Amended Certificate of Designation increased the number of authorized preferred shares under the designation for our Series 1 Preferred Stock from 3,000,000 shares to 4,000,000 shares.

For the nine months ended June 30, 2021, 198,316 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

During the nine-month period ended June 30, 2021, the Company retired 469,949 shares of Series 1 Preferred Stock surrendered by Aron Govil as part of the settlement agreement (see Note 2).

As of June 30, 2021, and September 30, 2020, there were 1,885,151 and 2,156,784 shares of Series 1 Preferred Stock issued and outstanding, respectively.

Series A Preferred stock

During the nine-month period ended June 30, 2021, the Company retired 1,000,000 shares of Series A Preferred Stock surrendered by Aron Govil as part of the settlement agreement (see Note 2).

As of June 30, 2021, and September 30, 2020, there were zero and 1,000,000 shares of Series A Preferred Stock issued and outstanding, respectively.

Series C Preferred Stock

On October 3, 2019, pursuant to Article IV of our Articles of Incorporation, our Board of Directors voted to designate a class of preferred stock entitled Series C Preferred Stock, consisting of up to one hundred thousand (100,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series C Preferred Stock are entitled to the number of votes equal to the result of (i) the total number of shares of Common Stock outstanding at the time of such vote multiplied by 10.01, and divided by (ii) the total number of shares of Series C Preferred Stock outstanding at the time of such vote, at each meeting of our shareholders with respect to any and all matters presented to our shareholders for their action or consideration, including the election of directors.

21

During the nine-month period ended June 30, 2021, the Company retired 50,000 shares of Series C Preferred Stock surrendered by Aron Govil as part of the settlement agreement (see Note 2).

As of June 30, 2021, and September 30, 2020, there were 50,000 and 100,000 shares of Series C Preferred Stock issued and outstanding, respectively.

Common Stock

The Company is authorized to issue 50,000,000 shares of common stock, $0.001 par value. As of June 30, 2021, there were 18,711,463 shares issued and outstanding and at September 30, 2020, there were 17,622,539 shares issued and outstanding.

During the nine months ended June 30, 1,088,924 shares of the Company’s common stock have been issued to satisfy $550,000 of notes payable, $191,556 in accrued interest, and $465,772 of excess value of shares issued recorded as interest expense. On June 30, 2021, 318,218 shares were granted to satisfy $400,000 of notes payable and $80,509 of excess value of shares recorded as interest expense. These shares were issued on July 2, 2021.

Shares Surrendered in Settlement

In March 2021, Mr. Govil returned to the Company 1,000,000 shares of Series A Preferred Stock, 50,000 Shares of Series C Preferred Stock, 469,949 shares of Series 1 Preferred Stock, and forfeited all outstanding options to purchase shares of commons stock (collectively, the “Securities”). For the purposes of accounting recognition, the Company determined the fair value of the Series A, Series C, and Series 1 Preferred stock based on the closing trading value of the Series 1 Preferred Stock on the date of the agreement. The options surrendered were valued using the Black-Scholes option pricing model.

NOTE 16 – SHARE-BASED COMPENSATION

For the nine months ended June 30, 2021, and 2020, the Company recognized $110,904 and $167,212 of share-based compensation expense on its outstanding options, respectively. As of June 30, 2021, $401,690 of unrecognized share-based compensation expense is expected to be recognized over a period of five years. Future compensation amounts will be adjusted for any change in estimated forfeitures.

NOTE 17 – COMMITMENTS AND CONTINGENCIES

The Company has moved its corporate activities to New York City with a month-to-month lease of 2,500 square feet of office space at a rate of $13,000 per month. The Company has recognized $117,000 of lease expense for this lease, for the nine months ended June 30, 2021.

The Company’s IS segment owns approximately 25,000 square feet of warehouse space in Manchester, PA and approximately 43,000 square feet of office and warehouse space in York, PA. The IS segment also leases approximately 15,500 square feet of warehouse space in Emigsville, PA from a third party in a three-year lease at a monthly rent of $4,555 expiring on August 31, 2022. The Company has paid $40,995 for this lease, for the nine months ended June 30, 2021.

The Company’s AT segment leases (i) approximately 6,700 square feet of office and warehouse space in Pune, India from a third party in an five year lease at a monthly rent of $6,453 (INR456,972) expiring on February 28, 2024, the Company has paid $58,077 for this lease, for the nine months ended June 30, 2021, (ii) approximately 30,000 square feet of office and warehouse space in Hauppauge, New York from a third party in a seven-year lease at a monthly rent of $28,719 expiring on March 31, 2027, the Company paid $258,471 for this property, during the nine months ended June 30, 2021 and (iii) approximately 9,400 square feet of office and warehouse space in Hampshire, England in a fifteen-year lease with at a monthly rent of $7,329 (£5,771) which expires on March 24, 2031 and contains provisions to terminate in 2026, the Company has paid $65,961 for this lease for the nine months ended June 30, 2021.

NOTE 18 - SUBSEQUENT EVENTS

Cemtrex has evaluated subsequent events up to the date the condensed consolidated financial statements were issued. Cemtrex concluded that the following subsequent events have occurred and require recognition or disclosure in the condensed consolidated financial statements.

In July of 2021, the Company issued 2,070,731 shares of common stock to satisfy $2,837,814 worth of notes payable and accrued interest.

22

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and their pricing; unexpected manufacturing or supplier problems; the Company’s ability to maintain sufficient credit arrangements; changes in governmental standards by which our environmental control products are evaluated and the risk factors reported from time to time in the Company’s SEC reports, including its recent report on Form 10-K. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

General Overview

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry technology company. The Company has expanded in a wide range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

The Company continuously assesses the composition of its portfolio businesses to ensure it is aligned with its strategic objectives and positioned to maximize growth and return in the coming years. During fiscal 2018, the Company made a strategic decision to exit its Electronics Manufacturing group by selling all companies in that business segment on August 15, 2019. Accordingly, the Company has reported the results of the Electronics Manufacturing business as discontinued operations in the Consolidated Statements of Operations and in the Consolidated Balance Sheets. These changes have been applied for all periods presented. During fiscal 2019, the Company also reached a strategic decision to exit the environmental products business, which was part of the Industrial Services Segment.

Now the Company has two business segments, consisting of (i) Advanced Technologies (AT) and (ii) Industrial Services (IS).

Advanced Technologies (AT)

Cemtrex’s Advanced Technologies segment delivers cutting-edge technologies in the Internet of Things (IoT) and Smart Devices, such as the SmartDesk. Through the Company’s advanced engineering and product design, the Company delivers Virtual Reality (VR) and Augmented Reality (AR) solutions that provide higher productivity, progressive design and impactful experiences for consumer products, and various commercial and industrial applications. The Company is in the process of developing its own virtual reality applications for commercialization over the next couple years.

The AT business segment also includes the Company’s majority owned subsidiary, Vicon Industries, which provides end-to-end security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides cutting edge, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

23

Industrial Services (IS)

Cemtrex’s IS segment, offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. We are a leading provider of reliability-driven maintenance and contracting solutions for the machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

Significant Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

Certain of our accounting policies are deemed “significant”, as they are both most important to the financial statement presentation and require management’s most difficult, subjective or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our significant accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended September 30, 2020.

Results of Operations - For the three months ending June 30, 2021, and 2020

Total revenue for the three months ended June 30, 2021, and 2020 was $10,326,431 and $8,440,867, respectively, an increase of $1,885,564, or 22%. Loss from operations for the three months ended June 30, 2021, was $2,300,269 compared to $2,399,802 for the three months ended June 30, 2020, a decrease on the loss of $99,533, or 4%. Total revenue for the quarter increased, as compared to total revenue in the same period last year, due to shutdowns and limited operations of businesses due to the COVID-19 crisis. Loss from operations decreased due to increased revenues as a result of the COVID-19 crisis during the same period last year.

Revenues

Our Advanced Technologies segment revenues for the three months ended June 30, 2021, increased by $868,534 or 17% to $5,845,958 from $4,977,424 for the three months ended June 30, 2020. This increase is mainly due to an improvement in economic climate from the impact of the COVID-19 crisis during the same period last year.

Our Industrial Services segment revenues for the three months ended June 30, 2021, increased by $1,017,030 or 29%, to $4,480,473 from $3,463,443 for the three months ended June 30, 2020. This increase is mainly due to an improvement in economic climate from the impact of the COVID-19 crisis during the same period last year.

Gross Profit

Gross Profit for the three months ended June 30, 2021, was $4,127,716 or 40% of revenues as compared to gross profit of $3,279,852 or 39% of revenues for the three months ended June 30, 2020. Gross profit increased in the three months ended June 30, 2021, compared to the three months ended June 30, 2020, due to increased revenues. The Company’s gross profit margins vary from product to product and from customer to customer.

24

General and Administrative Expenses

General and administrative expenses for the three months ended June 30, 2021, increased $322,301 or 6% to $5,670,019 from $5,347,718 for the three months ended June 30, 2031. General and administrative expenses as a percentage of revenue was 55% and 63% of revenues for the three-month periods ended June 30, 2021, and 2020. The decrease in General and Administrative Expenses as a percentage of revenue is the increase in revenues from the same quarter last year and the increase on a dollar per dollar basis is the result of increased legal, travel, marketing and sales expenses.

Research and Development Expenses

Research and Development expenses for the three months ended June 30, 2021, was $757,966 compared to $331,936 for the three months ended June 30, 2020. Research and Development expenses are primarily related to the Advanced Technologies Segment’s development of proprietary technology and further developments of the SmartDesk and Artificial Intelligence (AI) and next generation solutions associated with security and surveillance systems software.

Other Income/(Expense)

Other income/(expense) for the third quarter of fiscal 2021, was $3,468,649 as compared to $(1,823,967) for the third quarter of fiscal 2020. Other income/(expense) for the three months ended June 30, 2021, included the following one-time items (i) other income resulting from the forgiveness of our PPP loans of $3,349,700. Additionally, the company had realized and unrealized gains on marketable securities of $538,281.

Provision for Income Taxes

During the third quarter of fiscal 2021, the Company recorded an income tax provision of $40,759 compared to $7,658 for the third quarter of fiscal 2020. The provision for income tax is based upon the projected income tax from the Company’s various U.S. and international subsidiaries that are subject to their respective income tax jurisdictions and the Company’s projected ability to utilize net loss carryforwards.

Net income/(loss) attributable to Cemtrex, Inc. shareholders

The Company had a net income attributable to Cemtrex, Inc. shareholders of $1,098,013, or 11% of revenues, for the three-month period ended June 30, 2021, as compared to a net loss attributable to Cemtrex, Inc. shareholders of $4,195,676 or 50% of revenues, for the three months ended June 30, 2020. Net income/(loss) attributable to Cemtrex, Inc. shareholders increased in the third quarter as compared to the same period last year was primarily due to other income items mentioned above.

Results of Operations - For the nine months ending June 30, 2021, and 2020

Total revenue for the nine months ended June 30, 2021, and 2020 was $28,422,892 and $32,774,797, respectively, a decrease of $4,351,905, or 13%. Loss from operations for the nine months ended June 30, 2021, was $6,308,818 compared to $2,519,212 for the nine months ended June 30, 2020, an increase on the loss of $3,789,606, or 150%. Total revenue for the period decreased, as compared to total revenue in the same period last year, due to shutdowns and limited operations of businesses due to the COVID-19 crisis during the first two quarters of fiscal year 2021. Loss from operations increased due to decreased revenues due to shutdowns and limited operations of businesses due to the COVID-19 crisis during the first two quarters of fiscal year 2021.

Revenues

Our Advanced Technologies segment revenues for the nine months ended June 30, 2021, decreased by $2,382,816 or 13% to $16,006,241 from $18,389,057 for the nine months ended June 30, 2020. This decrease is mainly due to shutdowns and limited operations of businesses due to the COVID-19 crisis during the first two quarters of fiscal year 2021.

25

Our Industrial Services segment revenues for the nine months ended June 30, 2021, decreased by $1,969,089 or 14%, to $12,416,651 from $14,385,740 for the nine months ended June 30, 2020. This decrease is mainly due to shutdowns and limited operations of businesses due to the COVID-19 crisis during the first two quarters of fiscal year 2021.

Gross Profit

Gross Profit for the nine months ended June 30, 2021, was $12,062,070 or 42% of revenues as compared to gross profit of $13,974,442 or 43% of revenues for the nine months ended June 30, 2020. Gross profit decreased in the nine months ended June 30, 2021, compared to the nine months ended June 30, 2020, due to lower revenues. The Company’s gross profit margins vary from product to product and from customer to customer.

General and Administrative Expenses

General and administrative expenses for the nine months ended June 30, 2021, increased $957,001 or 6% to $16,337,200 from $15,380,199 for the nine months ended June 30, 2020. General and administrative expenses as a percentage of revenue was 57% and 47% of revenues for the nine-month periods ended June 30, 2021, and 2020. The increase in General and Administrative Expenses as a percentage of revenue is the reduction in revenues from the same period last year and the increase on a dollar per dollar basis is the result of increased personnel, legal and accounting fees, and marketing and sales expenses.

Research and Development Expenses

Research and Development expenses for the nine months ended June 30, 2021, was $2,033,688 compared to $1,113,455 for the nine months ended June 30, 2020. Research and Development expenses are primarily related to the Advanced Technologies Segment’s development of proprietary technology and further developments of the SmartDesk and Artificial Intelligence (AI) and next generation solutions associated with security and surveillance systems software.

Other Income/(Expense)

Other income/(expense) for the first three quarters of fiscal 2021 was $8,315,729 as compared to $(2,982,670) for the first three quarters of fiscal 2020. Other income/(expense) for the nine months ended June 30, 2021, included the following one-time items (i) the settlement with Aron Govil (see Note 2), generated other income of $3,674,165, (ii) employee retention credits of $736,899 (iii) other income resulting from the forgiveness of our PPP loans of $3,349,700. Additionally, the company had realized and unrealized gains on marketable securities of $2,407,647.

Provision for Income Taxes

During the first three quarters of fiscal 2021 the Company recorded an income tax provision of $168,190 compared to $197,201 for the first three quarters of fiscal 2020. The provision for income tax is based upon the projected income tax from the Company’s various U.S. and international subsidiaries that are subject to their respective income tax jurisdictions and the Company’s projected ability to utilize net loss carryforwards.

Net income/(loss) attributable to Cemtrex, Inc. shareholders

The Company had a net income attributable to Cemtrex, Inc. shareholders of $1,859,534, or 7% of revenues, for the nine-month period ended June 30, 2021, as compared to a net loss attributable to Cemtrex, Inc. shareholders of $5,850,395 or 18% of revenues, for the nine months ended June 30, 2020. Net income/(loss) attributable to Cemtrex, Inc. shareholders increased in the first three quarters as compared to the same period last year was primarily due to other income items mentioned above.

26

Effects of Inflation

The Company’s business and operations have not been materially affected by inflation during the periods for which financial information is presented.

Liquidity and Capital Resources

Working capital was $18,176,331 at June 30, 2021, compared to $23,285,122 at September 30, 2020. This includes cash and equivalents and restricted cash of $14,570,345 at June 30, 2021, and $21,072,859 at September 30, 2020, respectively. The decrease in working capital was primarily due to the reduction of the Company’s cash and equivalents, and trade receivables during the first and second quarters of fiscal year 2021.

Accounts receivable decreased $1,452,581 or 22% to $5,234,216 at June 30, 2021, from $6,686,797 at September 30, 2020. The decrease in accounts receivable is attributable to lower revenues in the first three quarters of fiscal year 2021 due to the COVID-19 crisis.

Inventories increased $1,875,591 or 28% to $8,669,397 at June 30, 2021, from $6,793,806 at September 30, 2020. The increase inventories is attributable to the purchase of inventories for new products the Company plans to ship in the future.

Operating activities used $6,178,550 cash for the nine months ended June 30, 2021, compared to using $3,385,727 cash for the nine months ended June 30, 2020. The decrease in operating cash flows was primarily due to the effect of the settlement agreement with Aron Govil and the discharge of the Company’s PPP loans.

Investment activities provided $154,326 of cash for the nine months ended June 30, 2021, compared to using cash of $5,990,926 during the nine-month period ended June 30, 2020. Investing activities for the first quarter of fiscal year 2021 were driven by the Company’s investment in Virtual Driver Interactive, MasterpieceVR Software, purchase of fixed assets, and marketable securities transactions.

Financing activities used $180,219 of cash in the nine-month period ended June 30, 2021, as compared to providing cash of $20,663,535 in the nine-month period ended June 30, 2020. Financing activities were primarily driven by payments on bank loans and notes payable and proceeds from the second round of Paycheck Protection Program loans.

We believe that our cash on hand and cash generated by operations is sufficient to meet the capital demands of our current operations during the 2021 fiscal year (ending September 30, 2021). Any major increases in sales, particularly in new products, may require substantial capital investment. Failure to obtain sufficient capital could materially adversely impact our growth potential.

Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our expansion goals and working capital needs.

27

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021. Based on their evaluation, our management has concluded that as of June 30, 2021, there is a material weakness in our internal control over financial reporting. The material weakness relates to the Company lacking sufficient accounting personnel. The shortage of accounting personal resulted in the Company lacking entity level controls around the review of period-end reporting processes, accounting policies and public disclosures. This deficiency is common in small companies, similar to us, with limited personnel.

Notwithstanding the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures as of June 30, 2021, were not effective, and notwithstanding the material weakness in our internal control over financial reporting described below, management believes that the unaudited condensed financial statements and related financial information included in this Quarterly Report fairly present in all material respects our financial condition, results of operations and cash flows as of the dates presented, and for the periods ended on such dates, in conformity with GAAP.

In order to mitigate the material weakness, the Board of Directors has assigned a priority to the short-term and long-term improvement of our internal control over financial reporting. Our Board of Directors will work with management to continuously review controls and procedures to identified deficiencies and implement remediation within our internal controls over financial reporting and our disclosure controls and procedures.

Changes in Internal Control Over Financial Reporting

While there was no change in the Company’s internal control over financial reporting during the Company’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting, the Company is taking steps to improve its internal controls by obtaining additional accounting personnel.

Limitations on the Effectiveness of Controls

Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

28

Part II Other Information

Item 1. Legal Proceedings.

NONE.

Item 1A. Risk Factors

See Risk Factors included in our Annual Report on Form 10-K for 2020.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the nine months ended June 30, 2020, the Company issued an aggregate of 1,088,924 shares of common stock in exchange for aggregate consideration of $1,707,328, which was used for working capital and research and development. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

29

Item 6. Exhibits

Exhibit No. |  | Description
2.2 |  | Stock Purchase Agreement regarding the stock of Advanced Industrial Services, Inc., AIS Leasing Company, AIS Graphic Services, Inc., and AIS Energy Services, LLC, Dated December 15, 2015. (8)
2.3 |  | Asset Purchase agreement between Periscope GmbH and ROB Centrex Assets UG, ROB Cemtrex Automotive GmbH, and ROB Cemtrex Logistics GmbH. (7)
3.1 |  | Certificate of Incorporation of the Company.(1)
3.2 |  | By Laws of the Company.(1)
3.3 |  | Certificate of Amendment of Certificate of Incorporation, dated September 29, 2006.(1)
3.4 |  | Certificate of Amendment of Certificate of Incorporation, dated March 30, 2007.(1)
3.5 |  | Certificate of Amendment of Certificate of Incorporation, dated May 16, 2007.(1)
3.6 |  | Certificate of Amendment of Certificate of Incorporation, dated August 21, 2007.(1)
3.7 |  | Certificate of Amendment of Certificate of Incorporation, dated April 3, 2015.(3)
3.8 |  | Certificate of Designation of the Series A Preferred Shares, dated September 8, 2009.(2)
3.9 |  | Certificate of Designation of the Series 1 Preferred Stock.(11)
3.10 |  | Certificate of Amendment of Certificate of Incorporation, dated September 7, 2017 (12)
3.11 |  | Certificate of Designations of Series B Redeemable Convertible Preferred Stock..(21)
3.12 |  | Certificate of Correction to the Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Cemtrex, Inc (6)
3.13 |  | Amended Certificate of Designation of the Series 1 Preferred Shares, dated March 30, 2020.(16)
3.14 |  | Certificate of Amendment of Certificate of Incorporation, dated July 29, 2020 (20)
3.15 |  | Certificate of Correction of Certificate of Incorporation, dated July 29, 2021, filed October 7, 2020 (9)
4.1 |  | Form of Subscription Rights Certificate. (10)
4.2 |  | Form of Series 1 Preferred Stock Certificate. (10)
4.3 |  | Form of Series 1 Warrant. (10)
4.4 |  | Form of Common Stock Purchase Warrant, dated March 22, 2019. (14)
10.1 |  | Amendment of the Term Loan Agreement between Vicon and NIL Funding, dated March 4, 2020.(17)
10.2 |  | Consulting Agreement, dated April 22, 2020 between Centrex, Inc. and Adtron, Inc. (5)
10.3 |  | Securities Purchase Agreement dated June 1, 2020 (18)
10.4 |  | Securities Purchase Agreement dated June 9, 2020 (19)
10.5 |  | Settlement Agreement and Release between Cemtrex, Inc. and Aron Govil dated February 26, 2021 (13)
14.1 |  | Corporate Code of Business Ethics.(4)
21.1* |  | Subsidiaries of the Registrant
31.1* |  | Certification of Chief Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2* |  | Certification of Vice President of Finance and Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1* |  | Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.
32.2* |  | Certification of Vice President of Finance and Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.
101.INS* |  | XBRL Instance Document
101.SCH* |  | XBRL Taxonomy Extension Schema
101.CAL* |  | XBRL Taxonomy Extension Calculation Linkbase
101.DEF* |  | XBRL Taxonomy Extension Definition Linkbase
101.LAB* |  | XBRL Taxonomy Extension Label Linkbase
101.PRE* |  | XBRL Taxonomy Extension Presentation Linkbase

* | Filed herewith
1 | Incorporated by reference from Form 10-12G filed on May 22, 2008.
2 | Incorporated by reference from Form 8-K filed on September 10, 2009.
3 | Incorporated by reference from Form 8-K filed on August 22, 2016.
4 | Incorporated by reference from Form 8-K filed on July 1, 2016.
5 | Incorporated by reference from Form S-8 filed on May 1, 20120
6 | Incorporated by reference from Form 8-K filed on June 12, 2019.
7 | Incorporated by reference from Form 8-K/A filed on November 24, 2017.
8 | Incorporated by reference from Form 8-K/A filed on September 26, 2016.
9 | Incorporated by reference from Form 10-Q filed on May 28, 2021.
10 | Incorporated by reference from Form S-1 filed on August 29, 2016, and as amended on November 4, 2016, November 23, 2016, and December 7, 2016.
11 | Incorporated by reference from Form 8-K filed on January 24, 2017.
12 | Incorporated by reference from Form 8-K filed on September 8, 2017.
13 | Incorporated by reference from Form 8-K filed on February 26, 2021.
14 | Incorporated by reference from Form 8-K filed on March 22, 2019.
15 | Intentionally left blank
16 | Incorporated by reference from Form 8-K filed on April 1, 2020.
17 | Incorporated by reference from Form 8-K filed on March 9, 2020.
18 | Incorporated by reference from Form 8-K filed on June 4, 2020.
19 | Incorporated by reference from Form 8-K filed on June 12, 2020.
20 | Incorporated by reference from Form 10-K filed on January 5, 2021.

30

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  | Cemtrex, Inc.
Dated: August 16, 2021 |  | By: | /s/ Saagar Govil
|  |  | Saagar Govil
|  |  | Chief Executive Officer
Dated: August 16, 2021 |  |  | /s/ Christopher C. Moore .
|  |  | Christopher C. Moore
|  |  | Chief Financial Officer and Principal Financial Officer

31